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Radiation-induced esophageal cancer can be a deadly and unfortunate secondary outcome of 
radiotherapy or chronic occupational exposure to radiation. Although the esophagus is known to 
be a radiosensitive organ, it is under studied and further information regarding how dose and 
radiation quality impact its sensitivity may provide strategies to prevent esophageal cancer. The 
purpose of this thesis was to understand factors that play a role in the tissue’s radiosensitivity 
that may relate to its cancer risk. In this study, we used two esophageal 3D models, as well as 
both human and mouse cells, to define radiation quality and dose dependent changes. The study 
details radiation-quality and dose dependent changes in: tissue morphology, MAPK/SAPK 
phospho-protein expression, crosstalk between the TGFβ and ATM pathways, and DNA damage 
kinetics. The results are complex, but provide not only radiation quality and dose dependent 
differences, but also species and cell type specific differences in response to radiation. The latter 
are especially critical to note when extrapolating results using different model systems.  In total, 
the results suggest that esophageal tissue is sensitive to high vs. low linear energy transfer (LET) 
radiation. In addition, radiation induced changes in phospho-expression may underlie the 
changes in tissue morphology and result from alterations in proliferation and/or differentiation. 




esophagus to radiation was not defined, these studies have provided relevant key findings to 
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CHAPTER 1 INTRODUCTION 
1.1.    Esophageal Cancer 
Esophageal cancer is one of the fastest growing cancers in the United States (Chai and Jamal 
2012), ranked the 6th most common globally (Umar 2008), with more than 450,000 people 
worldwide diagnosed with esophageal cancer each year since 2008 (Pennathur et al. 2013). 
Unfortunately, it is also a very deadly cancer with an overall 5-year survival rate of 15-25% for 
patients diagnosed with esophageal cancer (Pennathur et al. 2013). One risk factor for 
esophageal cancer is a history of exposure to ionizing radiation.  
Higher rates of esophageal cancer have been observed for different radiation-exposed 
cohorts,  such as Atomic bomb survivors exposed during World War II in Hiroshima and 
Nagasaki (Li et al. 2010). Higher rates of esophageal cancer have also been observed in 
individuals occupationtionally exposed to radiation, such as nuclear workers throughout the 
United States. In a mortality study of 15,727 former Los Alamos National Laboratory employees 
exposed to ionizing radiation, an increased risk of esophageal cancer was noted (Wiggs et al. 
1994). In a similar study of  45,000 workers from Oak Ridge National Laboratory and Rocky 
Flats Nuclear Weapons Plant, individuals chronically exposed to low doses of radiation had an 
increased risk of esophageal cancer  that was dependent upon the level of radiation exposure 
(Gilbert et al. 1989).  
Epidemiology studies compiling the outcomes of a number of primary cancers have 
shown secondary cancers to be a risk following radiation therapy, with 5% of secondary cancers 
thought to be due to radiotherapy, with remaining risk attributed to longer lifespan and genetics 
(Dracham et al. 2018). Secondary cancer is defined as cancer that occurs less than 5 years 




previous cancer (Travis et al. 2006).  Although radiation oncologists strive to maximize dose to 
tumor cells while limiting exposure to normal cells, toxicity to normal tissues is a dose limiting 
side effect (Baskar et al. 2012).  Organs especially affected are those nearest the radiation target, 
such as the esophagus for the breast and lung (Schaapveld et al. 2015).  Studies focusing on 
esophageal cancer have also noted that previous radiation therapy treatment is associated with an 
increase in this secondary cancer (Hall and Wuu 2003, Dracham et al. 2018). The total dose has 
also been shown to play a role in the risk of developing secondary esophageal cancer and 
estimated to be ~0.3 % per Sievert (Schena et al. 2017).   
Radiation exposures treating a number of different diseases have accumulated enough 
data to be able to study the risk of secondary esophageal cancer. For example, a large cohort 
used to define the risk of secondary esophageal cancer are patients treated for Hodgkin’s 
lymphoma. In a study of 19,882 patients treated with radiation for Hodgkin’s lymphoma, a 4.3-
fold increase risk of radiation induced esophageal cancer was observed. Additionally, another 
study revealed a standardized incidence rate of 2.0 for esophageal cancer following radiotherapy 
for Hodgkin’s lymphoma (Morton et al. 2014). Secondary esophageal carcinoma risks have also 
been shown for patients treated for breast cancer who underwent radiation therapy treatment 
(Micke et al. 1999). One study cites a 4.22 increased risk for esophageal adenocarcinomas in 
women who were previously treated for breast cancer between the years of 1973-1993 (Lamart et 
al. 2013). Additional studies support this increased risk of developing esophageal cancer 
following radiotherapy for breast cancer, documenting 252 cases of esophageal cancer in a 
cohort of 740 breast cancer patients (Morton et al. 2012).  
The dose received during radiotherapy to the primary target has also been shown to play 




increased risk was noted in patients who received greater than 30 Gy to the esophagus during 
treatment (Morton et al. 2014). An 8.3-fold increase in the development of esophageal cancer 
was observed with doses above 35 Gy as compared to women not receiving radiation therapy. 
Thus, both prior radiation treatment in the area of the esophagus as well as higher doses to the 
target result in an excess risk of developing secondary esophageal cancer. This points to the 
importance of improving radiotherapy techniques to limit normal tissue exposure and aid in 
reducing the occurrence of secondary carcinomas, which have doubled between the years of 
1975-2005 (Dracham et al. 2018). 
Conformal types of radiation therapy, which limit more of the dose to the target tissue, is 
one way to reduce dose to neighboring tissues and reduce secondary cancer risk. One type of 
conformal radiation therapy that has been used more widely is proton beam therapy. For 
example, one study (Yock et al. 2016) compared secondary cancers induced by proton therapy in 
the treatment of 59 medulloblastoma patients with a previous group that had used photons to 
treat this same cancer (Packer et al. 2013), observed no secondary cancers following proton 
therapy, but a 2% increase in secondary carcinomas with photon therapy. Additionally, in 
another cohort looking at 88 medulloblastoma patients who underwent proton or photon beam 
therapy, three children among the 45 photon treated group developed secondary cancers, whereas 
none of the 43 patients who received proton therapy did (Eaton et al. 2016). A study by Chung et 
al. (Chung et al. 2013) focusing specifically on esophageal secondary cancers, revealed 5.2% of 
the patients developed secondary esophageal cancer following proton therapy as compared to 
7.5% of the patients treated with photon therapy. Although proton therapy has been associated 
with a significantly lowered risk of secondary cancers, the follow up time in these studies was 




be needed to determine with more certainty whether proton therapy represents a lower overall 
risk for radiation induced secondary cancers.  
Other conformal radiotherapy treatments that have been used are intensity modulated 
radiotherapy (IMRT), conformal three-dimensional radiotherapy (3D CRT), and volumetric arc 
therapy (VMAT). In comparing these treatments IMRT has been shown to spare organs outside 
of the target area better than 3D CRT (Hall and Wuu 2003, Schena et al. 2017, Filippi et al. 
2018) and VMAT delivered dose in a shorter period of time than both CRT and IMRT (Rehman 
et al. 2018).  Similar to photon therapy total dose is also important in the relative risk for these 
more conformal treatments. In a study by Rehman et al., phantoms were used to evaluate the risk 
of secondary cancers and to calculate dose to the esophagus for patients treated for head and 
neck cancer with either VMAT, IMRT, or 3D CRT (Rehman et al. 2018). The standard dose in 
this study was 66 Gy with the maximum dose to the esophagus of ~23 +/-Gy for VMAT, 29 +/-
Gy for IMRT, and 40+/- Gy for 3D CRT. The probability of normal tissue complication was 
defined as 0.4 for VMAT, 0.7 for IMRT, and 4.2 for 3D CRT.  In comparing these modalities, 
the risk of secondary cancer was lowest for VMAT, with IMRT exhibiting a higher risk and 3D 
CRT having the highest risk of all (Rehman et al. 2018). Based on the higher dose predicted 
outside the target area for the 3D CRT using the phantom models, these results are likely 
expected. However, it should be noted that there is a risk for radiation outside of the target site 
for all conformal radiotherapies as well and thus some risk of secondary cancers might still be 
expected.  
In total these epidemiological studies indicate an association between prior radiation 
exposure and cancer development. However, the underlying mechanism for the development of 




factor that may play a role in the increased cancer predisposition of the esophagus to radiation is 
its increased radiosensitivity, thus a better understanding of this tissues response to radiation may 
aid us in defining ways to prevent secondary cancers following prior radiotherapy. 
 
1.2.    The Esophagus and Its Radiosensitivity 
 
To fully understand the effects of radiation on the esophagus it is important to understand its 
structure and the cell types that compose this organ. As most people are aware, the esophagus is 
a hollow tube within the center of our bodies, ~nine to ten inches in length, connecting the mouth 
to the stomach, which functions mainly to propel food to the stomach by peristalsis (Figure. 1) 






 At a tissue level, the esophagus can be divided into four distinct layers: mucosa, submucosa, 
muscularis propria, and adventitia, moving from the inner to the outer layers. The inner mucosa 
 






can also be further sub-divided into the stratified squamous epithelium, lamina propria, and 
muscalaris mucosae. The squamous epithelium layer protects the outer portion of the organ, 
whereas the lamina propria is a thin layer of connective tissue, and the innermost muscularis 
mucosa is composed of a thin layer of smooth muscle fibers. The submucosa contains blood and 
lymph vessels, which dilate as food passes down the esophagus, and the muscularis propria 
contains muscle layers formed by connective fibers that support motor function.  Lastly, the 
adventitia is a fibrous layer that covers the esophagus and connects it to the stomach (Oezcelik 
and DeMeester 2011). A visual image of these layers and their relationship to each other is 
shown in Figure 2 for both the human and mouse. The epithelium above the muscularis layer is 
the portion of the esophagus made up of flat, thin squamous cells, containing a basal, suprabasal 
layer, where most cancers of the esophagus begin. Thus, it is of particular interest to understand 
the effect of radiation on these particular esophageal tissue cells. Stem cells also make up a 
portion of the epithelial tissue and mutations caused by radiation in this cell type would be 









Stem cells are believed to reside within the basal cell layer of the epithelial tissue, but defining 
the exact location and markers for esophageal stem cells has been difficult and somewhat 
controversial. The current dogma is that a population of actively proliferating cells in the basal 
layer work to replenish cell populations in the suprabasal layer of the esophagus tissue (DeNardi 
and Riddell 1991).  Marques-Pereira and Leblond performed studies using thymidine 
incorporation to aid in identifying the location of stem cells and demonstrated that proliferation 
occurs in the basal layer of adult rat esophagus, and labeled cells underwent division, and moved 
upwards through the epithelium over a 12 h period (Marques-Pereira and Leblond 1965). A more 
recent study by Deward et al. (DeWard et al. 2014), using mouse esophageal organoids and cell 
lineage tracing, concluded that quiescent stem cells reside within the basal layer. In this latter 
study, slowly dividing cells were identified with cell surface marker, Sox2, suggesting a stem 
 
Figure 2.  An image of Hematoxylin and Eosin stained 
mouse and human esophageal tissue layers (modified 





cell nature for these cells. Further confirmation of their stem cell linage was the fact that Sox2 
positive cells had the ability to generate organoids from a single cell. In another study by Doupe 
et al., an inducible cre-lox system was used to follow a single cell colony within the esophageal 
epithelium in an adult transgenic mouse (Doupe et al. 2012). This cell lineage tracing experiment 
helped to further pinpoint and define the esophageal stem cell and its behavior. They observed 
that single labeled cell colony would increase in size over time, which led researchers to 
speculate that a progenitor population was actively dividing within this basal layer (Doupe et al. 
2012). Researchers were able to conclude that the esophageal epithelium contains progenitor 
cells that divide approximately twice per week, producing both cycling and differentiated cells in 
the process (Doupe et al. 2012). They determined that the stem cell population within the 
esophageal epithelium divide, differentiate and flatten as they move upward toward the lumen. 
Terminally differentiated cells are then shed within the lumen over time. Rapid cellular turnover 
was noted for esophageal epithelial cells, which is perhaps a key factor in the increased 
radiosensitivity of the esophagus (Squier and Kremer 2001), as the Law of Bergonié and 
Tribondeau (Haber and Rothstein 1969) notes rapid proliferation to be a characteristic of 
radiosensitive cells. However, rapid proliferation is likely just one factor involved in this tissue’s 
radiosensitivity and other factors may also be at play.  
The radiosensitivity of esophagus tissues and cells has been investigated using computed 
tomography (CT). Niedzielski et al. used CT to visualize changes in the mean length and volume 
of the esophagus (Niedzielski et al. 2017) following radiotherapy. CT imaging of the esophagus 
in 134 patients with non small cell lung cancer treated with IMRT was used to predict radiation 
toxicity.  Esophageal tissue expansion based on voxel-based relative volume changes pointed to 




authors concluded that radiation exposure triggered cellular proliferation which in turn increased 
the thickness of the esophagus tissue. Thus, it is possible that the increased thickening of the 
tissue induced by radiation may be a precursor for changes that in some patients lead to cancer. 
Whether all radiation qualities produce similar types of changes and effects to the esophagus is 
uncertain, thus it is important to better understand radiation quality differences.  
 
1.3 Radiation Quality and Its Impact on Biological Systems 
Typically radiation quality is a term used to describe radiation having differing Linear 
energy transfer (LET), or the amount of energy deposited in a material per unit distance (Blakely 
1984). Types of radiation with larger LETs also have a higher relative biological effectiveness 
(RBE), and thus are more effective in producing biological damage per unit dose (Newhauser 
and Durante 2011). Low LET radiation includes such things as X-ray and gamma radiation; and 
high LET radiation includes alpha particles and heavy charged particles, like Fe ions. Ionizing 
radiation is also known to interact with DNA molecules through both direct and indirect action, 
with high LET radiation interacting directly with DNA molecules and low LET producing 
damage primarily through indirect mechanisms (Han 2010). Thus, high LET is more effective in 
inducing double strand breaks per unit dose as compared to low LET radiation (Han 
2010). Therefore, it could likely be speculated that high LET radiation would be more damaging 
to esophageal tissue, however it is uncertain whether this greater damage translates to an increase 
in cell death or more transformed cells which would provide a greater risk for secondary cancer 
risk.  
Although both low and high LET radiation produce DNA double strand breaks, high LET 




irradiation, which results in more lethal damage (Pang et al. 2011). Using atomic force 
microscopy, Pang et al. identified DNA fragments within cells following either high LET Argon 
(390 MeV/u) or low LET Co-60 exposure and noted that high LET generated a significantly 
larger fraction of short DNA fragments (0-50 nm range). In addition, work has shown that DNA 
fragments negatively impact cell survival and repair (Pang et al. 2011).  Decreased cell survival 
and higher rates of apoptosis following high LET radiation as compared to low LET radiation 
was also noted in a study by Niemantsverdriet et al., comparing high LET carbon ions (90 
MeV/u) to low LET Cs-137 using irradiated human alveolar basal epithelium cells 
(Niemantsverdriet et al. 2012). Thus, at a cellular level high LET has been shown to be more 
effective in producing damage and lethal effects, however as mentioned increased levels of 
damage and lethal effects may or may not translate to a higher risk of cancer. 
 Even so, some work has revealed that high LET does have more effectiveness in inducing 
cancer, at least in some tissue types. For example Datta et al. used colorectal cancer cells and 
compared high LET 56Fe (1000 MeV/u) to low LET Cs-137 radiation, and found high LET 
radiation to be more effective in increasing cellular proliferation and reducing differentiation 
rates, which promoted tumorigenesis (2013). Forty-six tumors were observed following a 2 Gy 
high LET exposure, whereas thirty-six tumors were observed following the low LET exposure, 
suggesting a greater effectiveness for tumor-induction with high LET.  A possible contributing 
reason, and underlying molecular factor, for the higher effectiveness could be that β-catenin is 
induced to a greater degree following high LET as compared to low LET gamma radiation (Datta 
et al. 2013). β-catenin is an oncogene that plays multifunctional roles within the cell including a 
pivotal role in tissue homeostasis, and studies have revealed that aberrantly high expression is 




the molecular underpinnings for the greater effectiveness of high LET radiation (Newhauser and 
Durante 2011). High LET produces more lethal damage, however low LET produces more non-
lethal damages in the DNA which may cause mutations and result in a greater risk of cancer in 
subsequent years. In this study, we focus on understanding how radiation quality affects 
esophageal cells and esophageal tissues response to radiation. We use various 3D tissue culture 
models to more accurately mimic actual esophageal tissue and investigate factors that may be 
important in understanding esophageal cells increased risk of radiation-induced carcinogenesis. 
 Radiation quality effects in the esophagus have not yet been studied to our knowledge, 
however studies have been done using a tissue with a similar structure, the skin, and shown 
distinct effects depending on the quality of the radiation exposure.  Von Neubeck et al. 
investigated the effect of high and low LET radiation using three dimensional skin models, 
measuring proliferation, differntiation, and repair kinetics (2015). The study quantified the 
number of cells within the basal layer and the thickness of each layer within the 3D cultures. The 
study showed that low doses of oxygen (500 MeV/n), silicon (400 MeV/n)  and iron (600 
MeV/n) irradiation, disturbed the cell homeostasis within the 3D structures, promoting 
proliferation and differntiation of cells within the tissue. They concluded that radiation quality 
rather than dose was the key factor in determining the severity of the biological effect, but 
additionally noted that low doses of high LET exposure revealed complex radiation effects 
depending on the radiation quality.  Further radiation quality differences included an increase in 
the basal cell number and thickening of the epidermal layer following O ions, whereas following 
Fe ions basal cell numbers were reduced and a more minor change in the epidermal thickness 
was noted. Interestingly, another study using a 3D model system, organoids derived from crypt 




137 irradiation (Martin et al. 2020), again suggesting divergent biological effects by different 
radiation qualities. It is unclear what causes the contrary effects between low vs. high LET 
radiation, but a clue might be found in understanding differences in the interaction or function of 
key pathways, including Transforming Growth Factor Beta (TGFβ) and Ataxia Telangiectasia 
Mutated (ATM), at different doses and/or radiation quality exposures.  
 
1.4. Role of TGFβ and ATM Pathways in Radiation Response 
Transforming growth factor β (TGFβ) is thought to be important in mediating cellular and tissue 
responses to ionizing radiation as well as acting as a tumor suppressor in preventing the 
proliferation of a wide variety of cell types (Zhang et al. 2006). Thus, it is a key cytokine 
important in maintaining normal tissue homeostasis. Following radiation damage, work has 
shown that TGFb signaling is critical in activating the DNA damage response (DDR) (Li et al. 
2019). Recent work has shown TGF-b signaling is increased after damage through the 
stabilization of TBRII. This stabiliztion of TBRII was dependent upon ATM activation, which 
occurs following damage. Thus, these results provide a link between these major pathways and 
DNA damage. In support of elevated levels with radiation exposure, a study by Rybkina et al. 
revealed occupational workers exposed to chronic gamma ray exposure had elevated TGFβ 
levels in their blood as well as increased levels of T-helper cells (2018). In contrast, in cancer 
TGFβ acts as a tumor promoter, stimulating cell growth and cell invasion in late stage tumors 
(Dancea et al. 2009). In addition, upregulated TGFβ is believed to suppress activation of white 
blood cells in the tumor microenvironment preventing immune cells from responding to cancer 




the repair of DNA damage (Li et al. 2019) it is important to also understand ATM’s role in the 
cell.  
ATM is a protein kinase that has a multitude of functions within the cell. In normal cells, 
ATM maintains genomic stability. Following its activation, ATM protects cells from radiation 
damage and promotes cell survival. ATM regulates cell cycle checkpoints after radiation induced 
DNA damage, playing an especially important role in S phase. (Kirshner et al. 2006). It also is a 
sensor of DNA damage and phosphorylates down-stream proteins critical in responding to 
radiation and recruiting repair complexes (Estiar and Mehdipour 2018). 
As noted above studies have shown TGFb signaling to be ATM dependent, but other 
studies have also shown the importance of TGFb in regulating ATM in response to damage. For 
example, Kirshner and team demonstrated in human epithelial cells that TGFβ partially controls 
the DNA damage response by regulating ATM activation (2006). In this study, the loss of TGFβ 
reduced cellular response to damage and decreased the activity of ATM (Kirshner et al. 2006). 
The loss of TGFβ resulted in lower ATM phosphorylation and higher levels of radiation-induced 
damage in the epithelial cells (Kirshner et al. 2006). This study points out the reciprocal 
regulation of ATM and TGFβ. Other work using A549, adenocarcinomic human alveolar basal 
epithelial cells, confirmed TGFβ played a role in stimulating ATM activity, but noted it was not 
responsible for the fast activation of ATM and p53 following irradiation (Wiegman et al. 2007). 
In summary, this work identifies a connection and reciprocal regulation between the TGFβ and 
ATM pathways, but a complete understanding of this relationship and how it may differ 
depending on dose or radiation quality is not fully defined. Given the link with DNA damage (Li 
et al. 2019), one way to explore the pathways potential interactions is to study the kinetics of the 




1.5. Ionizing Radiation induced foci as a means to monitor DNA DSB  
  
 Following DNA damage, a number of proteins are recruited to the sites of double strand 
breaks to aid in its repair. Radiation induced foci, or RIFs, are the name given to the 
accumulation of proteins at or near the site of double strand breaks. As many response proteins 
are modified by phosphorylation, antibodies against these phosphorylation site have allowed 
scientists a way to identify and follow the kinetics of double strand breaks and their repair within 
cells (Labay et al. 2011). Studies quantifying radiation induced foci have been around for over 
two decades, however a gold standard initially used to study DSB induction and repair is pulsed 
field gel electrophoresis (PFGE). In this method cells are radiolabeled, collected after irradiation 
and placed into agarose plugs and lysed. Proteins and cellular components are removed in the 
lysing process and the agarose containing plugs, placed into a gel and pulse field electrophoresis 
is applied to elute the broken fragments of DNA from the plugs into the gel. The amount of DNA 
eluted into the gel is thus a measure of the amount of broken DNA. Although this had been the 
gold standard for many years, it is very labor intensive and requires higher doses to allow 
detection (typically >40 Gy). Thus, when the first study by the Bonner group revealed antibodies 
against the phosphorylated form of H2AX would allow detection of DSB within cells at lower 
doses (Rogakou et al. 1998), the field rapidly initiated the use of this tool.  Numerous subsequent 
studies uncovered the number of foci/ cell generally corresponded well with the number of DSBs 
in a cells (as identified by other means), although not usually showing equal absolute numbers. 
These studies allowed repair kinetics to be defined and modeled down to very low doses 
(Rothkamm and Lobrich 2003). However, drawbacks exist as well in scoring foci. Initially many 
researchers quantified foci by eye, which was labor intensive and subjective, but computer 




(Rothkamm et al. 2015, Barbieri et al. 2019). Nevertheless, an avalanche of subsequent foci 
studies has slowly revealed additional caveats that should be understood when attempting to 
define DSB levels by this method. 
 As noted, foci counting is effective in providing estimates of DSBs, however an 
individual foci does not necessarily indicate just one DSB. Work has shown that closely spaced 
foci may not be able to be resolved under the microscope or merge with those in close proximity 
(Barbieri et al. 2019). Costes et al. performed extensive RIF studies describing radiation quality 
dependent differences and repair kinetics and revealed different phospho-proteins may have 
unique radiation quality dependent kinetics (Costes et al. 2006). Using a low LET and high LET 
radiation quality (x-ray and Nitrogen 130 MeV/u respectively), they observed that the size and 
frequency of ATM foci were radiation quality dependent, with high LET exposures resulting in 
larger foci, that were induced more rapidly as compared with low LET (Costes et al. 2006). 
However, gH2AX foci showed similar maximum induction and repair kinetics following high 
and low-LET exposures exhibiting maximal levels up to 2 hr post exposure. In the current study, 
both a protein that resides within the chromatin, gH2AX, and a protein recruited to the sites of 
damages 53BP1 is monitored to define the induction and repair of DSBs, as well as the 
persistence of foci many days post exposure to better understand esophageal tissue’s sensitivity 
to radiation.  
 Studies over the past decades using gH2AX and 53BP1 as markers of DSBs have 
revealed some similarities and differences. Phosphorylation of H2AX has been the most widely 
used modification to define the kinetics of DNA damage and repair. After a DNA double strand 
break has been induced, the variant histone, H2AX is phosphorylated on Serine-139 at or near 




telangiectasia mutated and Rad3-related (ATR) or DNA-dependent protein kinase (DNA-PK), to 
form the phosphorylated form, gH2AX (Rothkamm et al. 2015). A difficulty in using this DSB 
marker to establish the number of DSB is that the variant histone is also modified during S phase 
when the chromatin is disturbed. Thus, cells in S phase or early G2 often exhibit an increase in 
gH2AX foci/cell. Tu et al., performed elaborate studies using HeLa cells to show that 
phosphorylation of H2AX can occur in some cases in the absence of any DNA damage (Tu et al. 
2013). Often however, foci in S phase cells look different and have a more of a pan-nuclear 
staining, thus another way to focus only on DNA damage foci is to eliminate cells showing a 
pan-nuclear sort of staining from the analysis (de Feraudy et al. 2010).  
 Given differences may exist between RIF kinetics dependent on the modified DNA 
response protein studied (Kurashige et al. 2016), it is often useful to monitor a second protein 
known to accumulate at DSBs, such as 53BP1. The DNA damage marker, 53BP1, is thought to 
be recruited to the site of DNA damage after gH2AX foci formation. 53BP1 (p53 binding protein 
1) has been shown to be important in the signaling and repair of double-strand breaks. As the 
name suggests, 53BP1 is a protein that binds to p53.  It also binds to damaged chromatin and is 
known to regulate DNA repair pathway choice (Panier and Boulton 2014). During G1, it 
stimulates non-homologous end-joining (NHEJ)-mediated DSB repair by hindering DNA end-
resection that occurs at a distance, which is needed for homologous recombination repair. The 
binding protein also regulates the cell’s response to DNA breaks and promotes repair via NHEJ 
(Panier and Boulton 2014). A number of studies suggest that ATM is the primary kinase 
activating 53BP1 following damage (Lee et al. 2010) although, another study indicates that 
53BP1 is not dependent on ATM for its activation and that DNA PKcs can also activate 53BP1 




foci/cell. In addition, exposure of rat thyroid cells to 2Gy irradiation shows that the number of 
foci/cell as defined using each marker produce very similar results (Kurashige et al. 2016). 
Monitoring both 53BP1 and gH2AX DNA damage markers in esophageal 3D tissue models will 
allow us to better understand esophageal tissue sensitivity to radiation and if unique differences 
are evident based on dose, radiation quality, or time.  
 
1.6 Different 3-D tissue models useful in studying environmental effects and mimicking in 
vivo esophageal exposures 
 
Different 3D model systems have been used to mimic the esophageal tissue. The 3D organotypic 
culture (OTC) is structurally and morphologically similar to a section of a normal esophageal 
tissue (Whelan et al. 2018). To set up OTC esophageal epithelial cells are seeded over a collagen 
matrix containing fibroblasts inside a transwell. The collagen fibroblast layer mimics the 
subepithelial lamina propria within the actual esophageal tissue (Figure 3A). Epithelial cells are 
layered over the fibroblast/collagen matrix and stimulated to divide by removing medium from 
the transwell and providing an air/liquid interface. Thus, OTC include both fibroblast and 
epithelial cells allowing insight into how radiation impacts both cell types and the 
communication between cells. A drawback of this model is that is does not originate from a 
single stem cell as the organoid model does. But this model system has been used extensively to 
study effects of growth factors and to model esophageal cancer (Michaylira et al. 2010, 
Natsuizaka et al. 2010), as well as various disease states such as Barrett’s esophagus (Yan et al. 
1997). Although to date no studies have been done investigating the effects of radiation using 
this esophageal 3D model system. 
A second less complex three-dimensional model is the esophageal organoid. Compared to 




containing a stem/progenitor cell (Figure 3B) and grown in Matrigel which serves as a basement 
membrane for the structure (Figure 3B). Similar to organotypic culture, organoids can be used to 
study cell interactions, proliferation, stress response, and communication mechanisms between 
cells within tissues and to obtain data closer to the in vivo situation (Whelan et al. 2018). 
Organoids are also less labor intensive to make and less variable, and can be produced in large 
numbers, in contrast to OTC. One recent study by Fernandez-Antoran et al. used both transgenic 
mouse models and OTC to study the effect of very low doses of cesium (50 mGy) (2019). This 
work revealed wild-type cells to be inhibited from proliferating following radiation, whereas p53 
mutant cells in the tissue were insensitive to low dose radiation and increased in number. This 
selective survival advantage of p53 mutant cells resulted in greater numbers of p53 mutant cells 
within the OTC. This study revealed that very low doses (50 mGy) of low LET radiation can 
potentially disrupt the normal homeostasis of the tissue, and result in an increase in mutant cells, 









Although no studies have been performed using esophageal OTC or organoids to study 
radiation quality effects, studies have been done using other tissues in 3D. For example, human 
lung epithelial cells show a decreased rate of proliferation, a lower level of DNA damage and 
fewer apoptotic cells following either Fe 600 MeV/n or Cs-137 exposure when cells were 
cultured in 3D as compared to 2D (El-Ashmawy et al. 2016). Thus, researchers concluded that 
Figure 3. Comparison of esophageal organotypic culture (OTC) and 
organoid 3D model systems. The preparation of an OTC is described in 
(A). Esophageal epithelial cells and fibroblasts are grown in mono-
cultures prior to being combined in a transwell plate. Fibroblasts are first 
layered in a collagen matrix on the bottom of the transwell, followed by 
epithelial cells on top. To initiate epithelial proliferation, medium is 
removed and the air-liquid interface between the medium and 
environment triggers division. The lower image shows an H&E stained 
OTC section with the various layers including the basement membrane 
and epithelial layers, nicely mimicking actual tissue. (B) Cartoon of how 
esophageal spheroid organoids compare to OTC. Matrigel and single 
cells are combined and plated to grow into a 3D structure. The bottom 
image on the right shows a H&E stained organoid section, revealing its 
epithelial layers mirroring the actual esophageal tissue’s epithelial 
portion, with the center containing the thin shedding cells which would 






the frequency of radiation induced effects were overestimated in 2D cultures (El-Ashmawy et al. 
2016). A similar study looking at radiation-induced damage in lung organotypic cultures, 
comparing 2D to 3D tissues, found 3D cultures exhibited less damage at various timepoints 
following ionizing radiation. Work by Wu et al. suggested radiation induced bystander effects 
were present both in exposed 2D or 3D cell cultures, however foci levels were significantly 
higher in 2D cultures following x-rays and carbon ions (Wu 2015). In addition, rectal tumors 
from patients have been used to construct patient derived organoids (PDX) and used to predict 
response to radiotherapy, as characterized by an increased radiation sensitivity. Of note, the PDX 
response to radiation predicted a patients’ response to radiation with 84.43% accuracy (Yao et al. 
2020). Thus, in summary 3D studies appear to show lowered levels of foci and accurately reflect 
a patient’s response to radiation, thus likely providing a more suitable model as compared to 2D 
for modeling radiation response in vivo.  
 
1.7 Scope of Study 
The primary objective of this thesis was to examine the radiosensitive properties of the 
esophagus following high and low LET radiation. It is hypothesized that: (1) radiation impacts 
the structure of esophageal tissues leading to a greater risk of damage with high LET radiation, 
(2) TGFβ and ATM pathways are key in the response to radiation, and (3) persistent levels of 








MATERIALS AND METHODS 
2.1 Defining Dose and Radiation Quality Effects Using Mouse Esophageal Organoids 
Phase contrast images of organoids following radiation (prior to fixation) appeared to show a 
thickening in organoid cell layers exposed to the greater dose of high LET radiation. This study 
was designed to more robustly quantify changes in the thickness of cell layers using images of 
fixed, embedded, sectioned and Hematoxylin & Eosin (H&E) stained organoids. The study 






Prior to irradiation at the Brookhaven National Laboratory (BNL), mouse organoids were prepared 
by our collaborators (ie., Dr. Rustagi) at the University of Pennsylvania using freshly isolated 
 
 
Figure 4. Representative H&E stained image of mouse esophageal 
organoid image and measurements defined for each organoid.  An 
example of a typical H&E stained esophageal organoid section (A). A 
graphical representation of the various tissue layers measured and 





mouse esophageal cells. Cultures were then transported to BNL and irradiated the following day 
and further cultured for 9 days prior to fixation. Samples were fixed and sent out to be paraffin 
embedded, sectioned, and placed on slides. One section of each sectioned sample was H&E 
stained.   
Doses: 0, 0.1, and 1 Gy  
Radiation quality exposures: Fe600 MeV/n and Cesium 
The irradiation, staining and images were all taken previously at Lawrence Berkeley National Lab 
(LBNL), and images were analyzed in the current study. 
Analysis: ImageJ was used to measure the basal cell layer, whole cell layer (from outer organoid 
to inner sloughing cells), length of total organoid, width of total organoid, and length of lumen 
(center pink portion) (see Figure 4B).  
Analysis criteria for inclusion of organoids for scoring: As organoids are within the matrix at 
different heights within the gel, when it is sectioned some will be cut off either near the very top 
or bottom of an organoid. and at different stages of development in some cases, therefore a criterion 
for exclusion was defined:  
1) Organoids sliced in such a way where no lumen or cell layers are observed  
2) Organoids where the outermost cell layer does not surround the entire organoid 
3) Organoids which are merged together.  
 
2.2. Defining Dose-response of MAPK/SAPK Signaling in Mouse Esophageal Organoids in 
Response to Fe 600 MeV/n Exposure 
The purpose of this experiment was multi-fold. As esophageal tissue is a radiation-sensitive tissue, 




radiation quality, Fe 600 MeV/u. We chose to center on the MAPK/SAPK stress pathway and 
defined expression at 24 hours following exposure using human esophageal organoid samples as 
a surrogate for human esophageal tissue. Our first objective was to define the dose-response pattern 
of protein expression in the MAPK/SAPK stress pathway following high LET radiation exposure. 
Secondly, as TGFb has an important role both in cancer and normal tissue homeostasis, and is 
induced with radiation, we wanted to better understand its role in regulating phospho-protein 
expression following radiation. In addition, ATM also plays a critical role in responding to 
radiation and DNA damage. More recent studies have indicated ATM and TGFb may 
cooperatively regulate cellular response to radiation (Wang et al. 2013, Overstreet et al. 2015, Park 
et al. 2015). Thus, a third part of this study was to define phospho-proteins which appear to 
coordinately regulate, and be perhaps uniquely regulated at low vs. high doses of high LET 
radiation. To investigate these latter questions various inhibitors and growth factors were added 
including: TGFb, TGFb inhibitor, ATM inhibitor, as well a combination of ATM and TGFb 
inhibitors.  
Human esophageal (3D) organoid samples were prepared by our collaborators (Dr. Rustagi) at 
the University of Pennsylvania.  
Doses: 0, 0.1 and 1 Gy  
Radiation quality: Fe600 MeV/n 
Samples were treated with: ATM Kinase inhibitor (ATMi), Transforming Growth Factor β 
(TGFβ), TGFβ inhibitor (TGFβi), or both ATMi and TGFβi, one hour prior to irradiation.  
Code names for each treatment group:  
Control= Sham irradiated  




+TGFβ = samples + TGFb  
+TGFβi = samples+ TGFβ inhibitor 
+ATMi + TGFβi = samples + ATM inhibitor and TGFβ inhibitor 
Concentrations of various chemicals used:  
ATM inhibitor (KU-55933): 5 µM  
TGFβ:1ng/ml (Stock is 1 mg/ml) 
TGFβ inhibitor (SD208):1 µM.  
Chemical additions were made 1 hr prior to radiation and samples collected 24 hr post exposure.  
The Milliplex Map 10plex human MAPK/SAPK Signaling Magnetic Bead Kit (Millipore Sigma, 
Burlington, Massachusetts) was used to determine changes in various phospho-proteins in the 
MAPK/SAPK pathway (Figure 5). The kit detects expression levels for 10 phosphorylated 
proteins in cell lysates: ATF2 (Thr71), JNK (Thr 183/Tyr 185), HSP27 (Ser 78), p38 (Thr 
180/Tyr 182), ERK/MAP kinase ½ (Thr 185/ Tyr 187), p53 (Ser 15), MEK1 (Ser 217/221), 
MSK1 (Ser 212), STAT1 (Tyr 701), and c-Jun (Ser 73). BW in the Pluth Lab performed the 
assay which was run on the Luminex machine (06/2019) at UNLV according to the standard 
protocol. Samples were run in duplicate with the exception of the control +TGFb sample and the 
ATMi+ TGFβi samples, which due to a low amount of lysate were only run once. The analysis 







2.3. A Comparison of SAPK/MAPK Phospho-Protein Response in Human and Mouse 
Esophageal Organoids Following Different Radiation Qualities  
The objective of this study was to understand the persistent stress response in esophageal tissue 
induced by various doses and radiation qualities. As a surrogate for actual esophageal tissue we 
utilized 3D esophageal organoid samples. Additionally, as many studies have been performed 
using mouse models, we wanted to define if different patterns of response are observed for 
human compared to mouse.  
 
Figure 5. MAPK/SAPK Stress Pathway. The MAPK 
family includes stress-activated protein kinases (SAPK) 
and Jun amino-terminal kinases (JNK) that are activated 
by environmental stressors, including radiation. The 
phosphorylated proteins under analysis are:  ATF2, JNK, 
HSP27, p38, Erk/MAPKinase 1/2, p53, MEK1, MSK1, 
STAT-1, and c-Jun, see phospho-sites under methods). 





Human esophageal (3D) and mouse esophageal (3D) samples were exposed to 0, 0.1 and 1 Gy 
high LET radiation (Fe600 MeV/n) and low LET radiation (Cs) at BNL. Esophageal samples 
included in the study are human EPC cell organoids 9 days post Fe600 exposure, mouse cell 
organoids 9 days post Fe600 exposure, human EPC cell organoids 9 days post Cs exposure, and 
mouse cell organoids 9 days post Cs exposure. Changes in various phosphoprotein expression 
were defined using the Milliplex Map 10-plex human MAPK/SAPK Signaling Magnetic Bead Kit 
(Millipore Sigma, Burlington, Massachusetts). The assay was performed at UNLV according to 
the standard protocol and samples were run in duplicate. The same sham irradiated sample was 
used as the control for both radiation qualities. The analysis was set up to define: (1) dose response, 
(2) radiation quality differences, and (3) species differences.  
 
2.4. Radiation Quality and Dose-dependent Effects on Persistence of ƔH2AX in Mouse 
Esophageal Organoids 
Mouse esophageal organoids were treated with Fe600 MeV/n or Cesium to compare radiation 
quality effects on the persistence of gH2AX in mouse 3D esophageal organoids. 3D Organoids 
were used to mimic in vivo tissues and stained for gH2AX, a marker of double strand breaks 







Esophageal organoids were prepared by our collaborators (Dr. Rustagi) at the University of 
Pennsylvania using mouse esophageal cells, basically as previously described (Kalabis et al. 2012). 
The organoids were seeded 1 day prior to irradiation and grown for nine days post exposure, or for 
10 days total growth, a timepoint when organoids are typically fully formed.  
Doses: 0, 0.1, and 1 Gy  
Radiation quality: high LET radiation (Fe 600 MeV/n) or low LET radiation (Cesium)  
Timepoint: Nine days post exposure (216 hours)  
Processing: organoids were fixed in formalin, sent to a core laboratory for paraffin embedding and 
sectioned onto slides. Slides were then processed and stained using DNA damage signaling 
protein/phosphoproteins γH2AX (1:800) (Figure 6).  Staining and images were completed 
 
 
Figure 6. Example of esophageal organoid stained for γH2AX foci 
following 0.1 Gy Fe600 MeV/n. γH2AX is labeled with Alexa 488 




previously at LBNL, and current analysis was performed using images taken from these stained 
sections. 
ImageJ was used to quantify fluorescent foci within the DAPI stained cells of the organoids.  
Slides were scored blindly for total number of foci-positive cells per organoid. A one-way 
ANOVA was used to test significance. 
Criteria for exclusion of images from scoring analysis:  
1) Partial organoids, where it was cut off in the image  
2) No clear staining of foci, green Alexa 488 signal was not sufficient to allow detection 
3) Unclear staining of cell nucleus. Blue DAPI staining to identify each nucleus was sub-
optimal. 
 
2.5 Radiation and Dose-dependent Impact on 53BP1 Foci Persistence in Esophageal Mouse 
Organoids 
This experiment examined differences in radiation quality effects between high (Fe600 MeV/n) 
and low LET (Cs) radiation using a three-dimensional (3D) mouse esophageal organoid to best 
mimic in vivo effects.  Organoids were prepared by our collaborators (Dr. Rustagi) at the 
University of Pennsylvania using mouse esophageal cells, basically as previously described 
(Kalabis et al. 2012). Organoids were seeded 1 day prior to irradiation and grown for nine days 
post exposure, a time point where organoids should typically be fully formed (day 10).  
Exposure doses: 0, 0.1 and 1 Gy  
Radiation qualities: Fe 600 MeV/n or Cesium irradiated at BNL 




Processing: organoids were fixed in formalin, sent to a core laboratory to be paraffin embedded 
and sectioned onto slides. Slides were then processed and stained using a fluorescently tagged-
antibody against 53BP1, a protein known to accumulate at the sites of double strand breaks 
(DSBs). Staining and imaging of the organoids were done at LBNL, but levels of 53BP1 foci 









Figure 7. Representative image of mouse esophageal 
organoid exposed to 0.1 Gy Fe600 MeV/n and stained for 
53BP1 foci. 53BP1 is labeled with Alexa 488 (green) and cell 
nuclei are counterstained with DAPI (blue). The representative 
image shows r cells within the organoid that contain foci (within 
red circles). This organoid would be scored as having 53BP1 





ImageJ was used to quantify fluorescent foci within DAPI stained nuclei of cells within the 
organoid. For each esophageal organoid the number of foci positive cells was defined.  
Figure 7 shows a representative organoid image post a 0.1 Gy dose of Fe 600 MeV/n. Data 
obtained from each image include:  
1) Total number of organoids 
2) Number of 53BP1 foci-positive cells 
3) We also recorded the number of pan stained cells within the organoids. Pan stained cells 
do not have distinct foci, but instead have an entirely green fluorescent nucleus. 
 
2.6. gH2AX Kinetics in Human Esophageal Organotypic Cultures Following Fe 600 MeV/n 
Exposure 
 
Tissue culture studies done in two dimensions (2D), or in a standard mono-culture, may not 
accurately reflect what occurs in vivo. Thus, to better understand how radiation may impact cells 
and tissues in vivo we used three-dimensional (3D) esophageal organotypic cultures (OTC) to 
examine DNA damage response following high LET radiation using the double-strand break 
marker gH2AX.  
  Human organotypic cultures (OTC) were seeded by our collaborators (Dr. Rustagi) at the 
University of Pennsylvania using human esophageal cells, transported to BNL for analysis and 
irradiated 6 days post set up. Human esophageal epithelial cells (referred to as EPC) and human 
esophageal fibroblast cells (referred to as FEF3) were used to seed OTC cultures. At the 
appropriate timepoint, cultures were fixed and sent to a core laboratory for paraffin embedding, 




signaling protein gH2AX at LBNL and imaged. Analysis and quantification were performed 






Doses: 0, 0.1 and 2 Gy  
Radiation quality: Fe 600 MeV/n irradiated at BNL 
Timepoints: 2, 24, and 72 hours post exposure  
Analysis: Images were adjusted for fluorescent intensity equally between images using imageJ. 
Figure 8 shows a representative OTC image 2 hr post a 0.1 Gy dose.   
All images were coded and scored blindly. 
  
Figure 8. Example of OTC 3D tissue culture 
stained with	gH2AX 2 hours post 0.1 Gy.  gH2AX 
foci (green) and ATF2 Ser 490/498 (red) foci are 
shown within DAPI stained cell nuclei (blue). 
Epithelial cells are above a matrix containing 
fibroblasts as shown and images scored for number 
of total cells, % of foci positive cells and number of 





Data obtained from each image include: 
1) Total number of DAPI positive cells in the epithelial and fibroblast layers  
2) Percentage of foci positive cells in the epithelial and fibroblast layers 
3) Total number of foci in each foci-positive cell in epithelial and fibroblast layers. 
 
2.7 53BP1 Kinetics in Human Esophageal Organotypic Cultures Following  
Fe 600 MeV/n Exposure 
To examine the DNA damage response and repair kinetics as defined by 53BP1 foci in three-
dimensional (3D) human esophageal organotypic cultures (OTC) following high LET Fe 600 
MeV/n radiation. This work will be compared to similar OTC stained for gH2AX, another DNA 
damage marker, to define similarities and differences.  
Human OTC were prepared by our collaborators (Dr. Rustagi) at the University of Pennsylvania 
using human esophageal cells. Human esophageal epithelial cells OTC were fixed, paraffin 
embedded and sectioned onto slides. Slides were then processed and stained using an antibody 
against 53BP1, a protein known to be recruited to sites of DNA double-strand breaks (DSB). 
Staining and imaging of the OTC sections were done at LBNL, but were analyzed and quantified 








Doses: 0, 0.1 and 2 Gy  
Radiation quality: Fe 600 MeV/n 
Timepoints: 2, 24, and 72 hours post exposure 
Analysis: ImageJ was used to quantify fluorescently tagged 53BP1 foci within the DAPI stained 
cells. Epithelial and fibroblast layers were scored separately to define differences in radio-
sensitivity between each cell type. Figure 9 shows a representative OTC image 72 hr post a 2 Gy 
Fe 600 MeV/n exposure.  Slides were scored blindly. 
Data obtained from each image  analyzed included: 
1)Total number of DAPI positive cells in the epithelium and fibroblast layers 
 
 
Figure 9. OTC section stained for 53BP1 foci 72 
hours post 2 Gy. 53BP1 foci are labeled with Alexa 
488 (green) and cell nuclei are counterstained with 
DAPI (blue). Division between Epithelial and 





2) The percent of foci positive cells 
3) The number of foci per cell  
 
2.8 Statistical analysis 
Data were analyzed and graphed using GraphPad Prism version 8, with the exception of Milliplex 
multiplex assay. Statistical significances were calculated using one-way ANOVA. Values were 
considered significant when the p-value was below 0.05.  
Multiplex assay data were shared with a statistician who determined significance, and are 











3.1 Dose and Radiation Quality Effects Using Mouse Esophageal Organoids 
Organoids within the H&E sections for each treatment group were first measured for the 
thickness of whole cell layer (Figure 4B). The whole cell layer constitutes both the basal and 
suprabasal layers. A significant dose and radiation quality dependent increase in the thickness of 
the whole cell layer was observed following high LET (Fe 600 MeV/n) exposure (Figure 10). 
Significant differences were noted between organoids exposed to 0 and 1 Gy Fe 600 MeV/n 
(p<0.05). Interestingly, low LET (Cs) exposed organoids demonstrated a similar dose response 





Figure 10. Dose and radiation quality dependent changes in the thickness of mouse 
esophageal organoid tissue layers following radiation. Mouse esophageal epithelial cells 
were used to set up organoids and exposed to various doses (0.1 and 1 Gy) of Fe 600 MeV/n or 
Cesium. The thickness of whole layer (as defined in Figure 1) was quantified following the 
different doses and radiation quality exposures. Significant differences are noted between 0 






























Next, the most outer basal, single cell layer (Figure 11A) of the organoids was measured. 
The “single cell layer” measurement represents the average size of the basal layer.  The thickest 
portion of this outer single cell layer was measured. The thickness of the single cell layer (as 
defined in Figure 4B) was quantified following different doses and radiation quality exposures. 
No significant changes were observed in the average thickness of this single basal cell layer 
following high LET (Fe600 MeV/n) or low LET Cs exposure as compared to controls (Figure 
11A).    
Next, we analyzed the total length (Figure 11C) and width (Figure 11D) of the organoids 
to evaluate overall size changes. No significant changes were observed in the average length and 
width of organoid following high LET (Fe600 MeV/n) exposure as compared to control organoids. 
However, a non-significant increase was observed in the width of the diameters as dose increased 
(Figure 11D). No significant changes were observed in either length or width following Cs 
exposure, although the highest dose did show in both cases an increase over the control and lower 
dose.  Lastly, the lumen was analyzed for differences between the different radiation qualities and 
controls. The lumen is the area of the esophagus where differentiated cells are sloughed off and 
discarded.  The lumen (as defined in Figure 4B) was measured following the different doses and 
radiation quality exposures. The average diameter of lumen for the high LET (Fe600 MeV/n) 0.1 
Gy exposed organoids demonstrated a non-significant increase in size as compared to controls. 
Whereas a non-significant decrease was observed for organoids exposed to 1 Gy Fe600 MeV/n as 
compared to 0.1 Gy. (Figure 11B). Similarly, Cs exposed organoids revealed a similar trend with 
a non-significant increase between 0 and 0.1 Gy and non-significant decrease between 0.1 and 1 







3.2 Dose-response of MAPK/SAPK Signaling in Mouse Esophageal Organoids in Response 
to Fe 600 MeV/n Exposure 
 
In this work a multiplexed assay was used to define the expression of 10 phospho-proteins in the 
MAPK/SAPK stress pathway (Figure 5). The exact phospho-sites are detailed under the 
methods section. To first define the dose-response of stress pathway phospho-protein expression 
patterns following Fe600 MeV/u irradiation, we determined the fold change following each dose 
as compared to sham irradiated samples. We then grouped the fold change of phospho-proteins 
showing similar increasing or decreasing trends following a low (0.1 Gy) or a higher (1 Gy) 
Figure 11. Other measurements of mouse esophageal 
organoids following Fe 600 MeV/n or Cesium 
exposure. The most outer basal single cell layer was 
measured (A), or the internal lumen diameter (B) or the 
total length (C) or width (D) was measured for each 


























































































dose. Folds > 1.1 were designated as having an increasing trend and those less <0.9 a decreasing 
trend, whereas folds between these two were categorized as unchanged (Appendix I).  
In Figure 12 we graph those showing similar trends for a low vs. a higher dose exposure. No 
significant changes in the expression of any phospho-sites with either a low or a higher dose as 
compared to sham was observed. However, following 0.1 Gy irradiation, we do observe a similar 
trend for a group of phospho-proteins of an increased expression at the low dose, including 
Erk/MAPKinase 1/2, p53, MEK1, and MSK1 (Figure 12A). The remaining phospho-proteins 
(ATF2, JNK, HSP27, p38, STAT-1, and c-Jun; Figure 12B) showed a very minor change in fold 
expression (>1.1 or < 0.9). Following a higher 1Gy exposure, a decrease in expression was 
observed for a number of phospho-proteins that had shown the opposite trend at the low dose 
(Erk/MAPKinase 1/2, p53, and MEK1) as well as two additional phospho-proteins (p38 and c-
Jun, Figure 12C). Similarly, we also observed for the higher dose no major fold change in the 
same phospho-proteins unaltered at a lower dose (ATF2, JNK, HSP27, and STAT1) as well as 
no change in one that had revealed an increased expression at a low dose (MSK1, Figure 12D).   
When comparing expression patterns between all doses, a dose-dependent decrease was 
observed for the expression of phospho-protein p38 (Figure 12E).  In addition, three phospho- 
proteins showed a trend in which the lower dose had a greater level of expression than a higher 











Figure 12. Dose-response expression of phospho-protein’s in the 
stress pathway in human esophageal organoids. Phospho-proteins 
showing a trend of increased expression with low dose radiation (0.1 
Gy; (A) and those showing no major fold change (folds between 0.9-
1.1; (B). Following a higher dose (1 Gy) proteins showing a trend of 
decreased expression (C) and those showing no major fold change 
(D). One phospho-protein, p38, showed a dose dependent decrease 
(E) and three phospho-proteins showed the highest expression level 
at a low dose (F). A significant difference in Erk/MAPK expression 









Figure 13. Effect of ATM inhibition on expression of stress pathway phospho-proteins. Phospho-protein 
expression for Sham IR samples, without (blue bar) and with the ATM inhibitor (beige bar) showing a 
decreasing trend (A), of note HSP27 and p38 show a significant decrease. The remaining sham IR showed no 
major fold change (B). Following the low 0.1 Gy exposure, phospho-proteins showing a decreasing trend (C) 
are noted, with p53 showing a significant decrease.  p38 was the only phospho-protein at a low dose showing a 
slight increase (D) with ATM inhibition. The remaining phospho-proteins following a low dose showed no 
change (E) in comparing sham to +ATMi samples. Lastly, phospho-proteins following a higher 1 Gy dose 
which showed a decreasing trend with ATM inhibition (F) were graphed together, with ATF2 showing a 
significant decrease.  A slight increase with 1 Gy and inhibitor as compared to no inhibitor was only observed 
with Erk/MAPk (G) and no change was observed with the remaining phospho-proteins (H) as compared to 1 Gy 
exposure alone.  Dose-dependent trends were only noted for ATF2 (I) which showed a decrease with dose, note 
blue is level expressed with ATMi and beige portion additional expression in control samples without inhibitor 




To better understand the role of ATM in the stress response to radiation we used an ATM 
inhibitor to define how phospho-protein expression patterns changed as compared to no inhibitor 
at each dose and sham. Without radiation exposure, a number of phospho-proteins decreased as 
compared to sham (Figure 13A; HSP27, p38, Erk/MAPKinase ½, p53, MEK1, MSK1, and 
STAT1), with HSP27 and p38 showing a significant decrease + ATMi as compared to sham. 
Three phospho-proteins showed no major fold change (ATF2, JNK, and c-Jun) +/- ATMi 
(Figure 13B).  When comparing phospho-protein expression with ATMi following a low 0.1 Gy 
dose, most phospho-proteins, similar to no dose, showed a slight decrease in expression (Figure 
13C), with p53 showing a significant decrease. Unique to the low dose, one phospho-protein, 
p38, showed a slight increase (Figure 13D), and no change was observed with the remaining 
phospho-proteins (Hsp27, MSK1, STAT1, Figure 13E).  The decreased expression observed 
with addition of the ATM inhibition implies ATM is important in increasing the expression 
levels of these phospho-proteins, particularly p53 following a low dose. Moving to a higher 1 Gy 
dose in the presence of the ATMi resulted in fewer phospho-proteins showing a decrease in 
expression (ATF2, HSP27, and STAT1; Figure 13F), with only ATF2 showing a significant 
decrease. One phospho-protein showed a slight increasing trend in expression, Erk/MAPK 
(Figure 13G), and the rest showed no major fold change (Figure 13H) following a 1 Gy dose. 
Comparing across doses, a dose dependent trend was observed only for ATF2 (Figure 13I), with 
increasing dose causing a decrease in its expression with ATM inhibition. This would suggest 
that ATM is important in increasing the expression of this phospho-protein in a dose-dependent 
manner. 
 TGFb, a cytokine that epithelial and fibroblast cells within tissues often express 




phospho-proteins in the stress pathway would be affected following a low vs. high dose. In the 
absence of radiation, the addition of TGFβ in most cases caused a decrease in phospho-protein 
expression (Fig 14A and B), or in just one case, MSK, no change in expression (Figure 14C). 
The majority of phospho-proteins also showed a decrease in expression following a low 0.1 Gy 
dose exposure (Figure 14D), or no change in expression (Figure 14E) with the addition of 
TGFb as compared to sham.  Following a higher 1 Gy dose, many phospho-proteins also showed 
a decrease in expression (Figure 14F) or no change (Figure 14G), although for p53 there was an 
increase following 1 Gy exposure (Figure 14H). In looking at the response over the range of 
doses only Hsp27 showed a dose-dependent increase (Figure 14I) in expression with 
TGFb addition. 
To gain further insight into the role of TGFb in the stress pathway following radiation, 
we also inhibited TGFb with the addition of SD208, a specific TGFb inhibitor. With no dose, we 
observed a decrease in expression of a number of phospho-proteins (ATF2, Erk/MAPK, MEK1, 
STAT1, c-Jun; Figure 15A), an increase in the expression of JNK (Figure 15B), or no change in 
a sub-set (Hsp27, p38, p53 and Msk1; Figure 15C).  Following a low dose, the majority of 
phospho-proteins also showed a decrease in expression (Figure 15D and E), with only JNK 
(Figure 15F) showing a slight increased expression following a low dose. Following the higher 
dose, a decreased expression of a number of phospho-proteins was observed (ATF2, JNK, 
HSP27, MEK1, STAT1; Figure 15H). A few phospho-proteins showed an increase (Figure 








Figure 14. Effect of TGFβ addition on MAPK/SAPK phospho-protein expression following various doses 
of Fe600 MeV/n. Phospho-proteins showing a decreased fold expression with TGFβ addition (A), with a 
significant decrease note for p38 as compared to sham (B). Those failing to show a major fold change as 
compared to sham (C). Phospho-proteins showing a slight decrease (D) or no change (E) following 0.1 Gy 
irradiation in the presence of TGFb compared to sham. Phospho-proteins showing a decrease with TGFβ 
addition (F) with a 1 Gy dose, or no change (G), or in one case an increase, as noted with p53 (H). Over the 
range of doses, only one phospho-protein exhibited a dose dependent response, HSP27, exhibiting a dose-
dependent increase with TGFb addition. Dark aqua portion of the bar is the level induced + TGFb and the dark 
gray the difference in the expression as compared to control level at each dose (I). *p<0.05 and **** p<0.0001. 






In comparing responses across all doses only Hsp27 showed a dose-dependent pattern of 
decreasing levels with increasing dose when TGFb was inhibited (Figure 15J), which was 






Figure 15. Effect of TGFβ inhibition on expression of phospho-proteins in the MAPK/SAPK stress 
pathway. Phospho-proteins showing a decrease with TGFβ inhibition (A), an increase (B), or no change as 
compared to sham (C). Phospho-proteins showing a slight decrease (D and E) and those showing an increase 
(F) with TGFβ inhibition plus a 0.1 Gy dose as compared to 0.1 Gy alone. Phospho-proteins showing an 
increase, in expression +TGFβ inhibition following a 1 Gy dose (G), or a decrease (H) or no change (I) as 
compared to 1 Gy alone. Looking at the response over the range of doses only Hsp27 showed a pattern of 
decreasing expression with increasing dose, dark portion of bars is amount expressed + TGFb inhibition and 






To uncover potential cross talk between the ATM and TGFb pathways, we then also 
inhibited both ATM and TGFβ and observed how phospho-protein expression in the stress 
pathway changed with a low vs. a higher dose. In the sham irradiated samples, we observed for 
all phospho-proteins a decrease in expression (Figure 16A) with a few showing no major fold 
change in their expression relative to control (ATF2, p53, and MEK1; Figure 16B). Comparing 
the expression following 0.1 Gy exposure, again for the majority we observed a decrease in  
expression (Figure 16C) with only two (p53 and MEK1, Figure 16D) showing no change in 
expression. Following a 1 Gy exposure, we observed fewer phospho-proteins showing a decrease 
in expression (ATF2, MSK1, and STAT1; Figure 16E), with a few showing an increasing trend 
in expression (JNK, p53, cJun; Figure 16F), and the remainder showing no change (Figure 
16G). When looking across doses two phospho-proteins showed some dose-dependent responses 
(Figure 16H and I). Hsp27 showed a dose-dependent increase in response (Figure 16H), which 
was opposite of what was observed with TGFb inhibition alone (no dose-dependent trend was 
observed with ATM inhibitor alone). MSK1 showed a pattern of decreasing levels with 
increasing dose in the presence of both inhibitors (Figure 16I) which was not observed with 
either inhibitor separately. 
To define whether unique patterns are observed with addition of both inhibitors, 
suggesting cross-talk between the pathways, we graphed control, +ATMi, +TGFbi and the 
combined inhibitor exposure (Figure 17) together. Following no dose, a number of  
phospho-proteins in the presence of both inhibitors expressed levels similar to ATMi alone 
(Hsp27, p38, ATF2 and MSK1; Figure 17A). A few behaved similarly to TGFbi alone 




Jun (Figure 17C), suggesting TGFb and ATM may co-regulate their expression in the absence of 
radiation exposure. 
Following a 0.1 Gy exposure, unique expression patterns in the presence of both inhibitors were 
observed for MEK1, p53, p38, MSK1 and STAT1, with levels differing from either +ATMi or 
+TGFbi addition alone (Figure 17G & H). Lastly, following a 1 Gy dose, three phospho-proteins 







Figure 16. Combined effect of ATM and TGFβ inhibition on the expression of phospho-proteins in 
the MAPK/SAPK stress pathway.  The majority of un IR samples showed a decrease in phospho-
proteins expression with the addition of the combined inhibitors (A) with Hsp27 and p38 showing a 
significant decrease. A few samples also showed no change as compared to no dose alone (B). Following a 
low 0.1 Gy exposure again most phospho-proteins showed a slight decrease (C), with Erk/MAPK showing 
a significant decrease. Only two phospho-proteins, showed no change in expression with the addition of 
the combined inhibitors (D) as compared to 0.1 Gy exposure alone. Following a higher 1 Gy dose, fewer 
phospho-proteins showed a slight decrease with the addition of both inhibitors (E), with three showing an 
increase (Jnk, p53 and c-Jun; F) or no change (G) as compared to 1 Gy exposure alone only. Comparing 
responses across the entire dose range, a dose-dependent increase was observed for HSP27 (H) and a dose-









Figure 17. Combined effect of ATM and TGFβ inhibition on the expression of 
phospho-proteins in the MAPK/SAPK stress pathway compared to single inhibitors 
or sham. Without radiation exposure the majority of phospho-proteins showed a similar 
expression as +ATMi samples alone (A), with a few showing a similar expression to 
+TGFβi alone (B).  Unique responses with no dose were observed for MEK1 and cJun (C), 
as well as JNK (D). With a low 0.1 Gy exposure again many phospho-proteins expressed 
levels similar to +ATMi alone (E) or +TGFβi alone (F). Unique responses were observed 
for MSK1, STAT-1, p53, MEK1 (G) and p38 (H). Following a higher 1 Gy dose, more 
phospho-proteins showed expression levels similar to +ATMi alone (I), with two phospho-
proteins expressing levels similar to +TGFβi alone (J). Unique responses were observed 








3.3 A Comparison of SAPK/MAPK Phospho-Protein Response in Human and Mouse 
Esophageal Organoids Following Different Radiation Qualities  
The aim of this study was to understand the impact of dose and radiation quality on esophageal 
tissue’s stress response and how this may differ between species. Mouse and human organoid 
samples were used to study persistent effects on the MAPK/SAPK stress pathway (nine days 
post exposure) following either a low or high LET radiation exposure (cesium vs. Fe 600 
MeV/n). A multiplexed assay was used to define the expression of 10 phospho-proteins in the 










Table 1.  Patterns of stress phospho-protein expressions with combined inhibitors 
 
 
No Dose Low Dose High Dose
Like ATMi Hsp 27, p38, ATF2, MSK1 JNK, ATF2, c-Jun STAT1, Hsp27, P38, MEK1, Erk/MAPK
Like TGFbi Erk/MAPk, p53, STAT 1 Hsp 27, Erk/MapK ATF2, c-Jun







We first compared expression patterns following exposure to the high LET radiation 
quality Fe 600 MeV/n in human esophageal organoid samples 9 days post exposure (Figure 18). 
Following a low 0.1 Gy dose, we observed ATF2, STAT-1, and c- Jun phospho-proteins to 
increase in expression as compared to sham (Figure 18A), with c-Jun significantly elevated from 
sham (p=0.001). Whereas phospho-proteins p53, MEK1, p38, and Erk/MAPK all revealed a 
decrease in expression as compared to sham (Figure 18B and 18C), with Erk/MAPK 
 
 
Figure 18. MAPK/SAPK stress phospho-protein dose-dependent expression 9 days post Fe 600 MeV/n 
exposure in human esophageal organoid samples. Graphs compare phospho-protein expression levels and 
reveal patterns in fold change. Phospho-proteins showing a fold increased fold (A), decrease fold (B and C), or 
no change (D) following 0.1 Gy as relative to controls. Following a higher 1 Gy dose phospho-proteins 
showing an increased fold (E and F), decreased fold (G), or no change (H) relative to controls. Graphing 
average expression across doses reveals increasing dose-dependent expression of ATF2 (I) whereas p38 
dependent decrease in expression (J).  Significant differences were noted between the doses for p53 (K), 




significantly decreased (p=0.01) as compared to sham. A few phospho-proteins revealed no 
major change in expression (JNK, HSP27, and MSK1) between the irradiated sample and control 
(Figure 2D). Following a higher 1 Gy dose, ATF2, STAT1 and c-Jun showed an increase in 
expression, similar to the low dose. Unique to the higher dose nearly all phospho-proteins 
showed an increase in expression (Figure 18E and 18F). Opposite patterns were noted between 
the low and high dose for p53, Mek1, and Erk/MAPK, which all decreased in expression 
following the low dose and increased in expression following a high dose as compared to sham.  
Expression of p38, similar to the low dose was decreased compared to sham following 1 Gy 
exposure (Figure 18G). Phospho-protein JNK, was the only phospho-protein to remain 
unchanged following the 1Gy exposure (Figure 18H). When comparing expression patterns 
between all doses, a dose-dependent increase was noted for ATF2 (Figure 18I), while a dose-
dependent decrease was noted for phospho-protein p38 (Figure 18J). In addition, a significant 
difference between the low and high dose was noted for p53 (Figure 18K), and Erk/MAPK 
(Figure 2L), with expression being much more elevated following the high dose. The opposite 
pattern was observed for c-Jun with the low dose significantly elevated from the high dose 
(Figure 18M).   
To better understand radiation quality differences in the expression of phospho-proteins 
in the stress MAPK/SAPK pathway, human esophageal organoids were studied following low 
LET cesium exposure at the same doses. When comparing fold changes for 0.1 Gy vs. sham, we 
noted an increase in the expression of phospho-proteins, ATF2, HSP27, STAT-1, and c-Jun 
(Figure 19A), and a decrease in JNK, MSK1, p38, and Erk/MAPK expression compared to sham 
(Figure 19B and 3C). The remaining phosphoproteins, p53 and MEK1, remained unchanged 




increase as compared to sham was noted again for phospho-proteins ATF2, STAT1, and c-Jun 
(Figure 19E). Whereas phosphoproteins JNK, HSP27, MSK1 and p38 all showed a decreased as 
compared to sham (Figure 19F-G). No change was observed for phospho-proteins Erk/MAPK, 
p53, and MEK1 (Figure 19H - 3I). Comparing across doses, we noted a dose-dependent 
decrease for phospho-protein JNK (Figure 19J). Erk/MAPk also showed a significant difference 
between the low and high dose, similar to what was observed following high LET, although the 







Figure 19. Impact of cesium exposure on MAPK/SAPK phospho-protein expression nine days post 
exposure in human esophageal organoid samples.  Phospho-proteins showing a fold increase (A), fold 
decrease (B and C) or no change (D) following 0.1 Gy compared to sham. Following a higher 1 Gy Cs exposure, 
phospho-proteins showing a fold increase (E), fold decrease (F and G), or no change (H and I) compared to 
sham. Lastly, looking at expression across the doses, JNK showed a dose-dependent decrease (J), ATF2, Hsp27, 
MEK1, STAT1, and c-Jun, p38, p53 and MSK1 showed similar levels between doses (K - M), and Erk/MAPK 
showed a significant difference between the low and high dose (L), *p<0.05; **p<0.01; *** p<0.001; **** 




Given many studies have been performed using mouse models, and data often need to be 
extrapolated from mouse to human, it is important to understand similarities and differences 
between these species. Thus, we also defined how the same radiation qualities impacted mouse 
esophageal organoid phospho-protein MAPK/SAPK expression.  Uniquely in mouse organoids, 
following the low 0.1 Gy dose, we observed an increased expression for all phospho-proteins 
(Figure 20A and 20B) except Erk/MAPK (Figure 20C), which remained unchanged. Following 
a higher 1 Gy dose, we again observed an increase in the expression of nearly all the phospho-
proteins (Figure 20D and 20E) with the exception of STAT-1 (Figure 20F), which showed a 








Figure 20. MAPK/SAPK phospho-protein dose-response in mouse esophageal organoids 
nine days post Fe600 MeV/n exposure. Following the 0.1 Gy dose the majority of phospho-
proteins showed an increased fold in expression (A and B) or no change (C) as compared to 
sham. Following a higher 1 Gy most showed an increased fold change (D and E), or in one 
case a decrease (F) as compared to sham. When comparing expression across doses a few 
showed a dose dependent increase in expression (G, H and I). Significant differences were 
noted between the doses for Erk/MAPK (J) with the higher dose showing the greatest values. 
Four other phospho-proteins revealed the lower dose to be significantly higher than the high 
dose (K), *p<0.05; **p<0.01; *** p<0.001; **** p<0.0001.   





















































































































































































































Likewise, we compared MAPK/SAPK phospho-expression in the mouse esophagus 
organoid tissue following low LET cesium exposure (Figure 20). Again, similar to the high LET 
results, following the low 0.1 Gy exposure the majority of the phospho-proteins showed an 
increased fold expression (ATF2, HSP27, p53, MEK1, MSK1, STAT1, c-Jun, JNK, and 
Erk/MAPK) as compared to sham (Figure 21A-B).  The only protein not showing an increase was 
p38 which did not notably change in expression levels between the 0.1 Gy exposure and sham 
 
Figure 21. Cesium’s impact on mouse esophageal organoid MAPK/SAPK 
stress pathway signaling nine days dose post exposure. The majority of 
phospho-proteins following Cs exposure were significantly increased following 
0.1 Gy as compared to sham (A-B), with only p38 showing no notable fold change 
(C). Following a higher 1 Gy dose, a number of phospho-proteins showed 
significant increases over control (D), but two showing a decreased fold (E) and 
two showing no major fold change from control (F). Viewing phospho-protein 
expression patterns across doses, a common pattern is for the low dose to show the 
greatest expression (G and H) *p<0.05; **p<0.01; *** p<0.001; **** p<0.0001. 
 













































































































































(Figure 21C). At the higher 1 Gy dose, we also observed an increased fold in the majority of 
phospho-proteins (Figure 21D), although two phospho-proteins, p38 and Erk/MAPK, showed a 
decreased fold change in expression as compared to sham (Figure 21E). Two phospho-proteins, 
STAT-1 and c-Jun remained basically unchanged following 1 Gy exposure as compared to sham 
(Figure 21F). Interestingly, a pattern observed following the Cs exposure in the mouse organoid 
samples was higher phospho-protein expression levels post the low dose levels as compared to 




Figure 22. A comparison of radiation quality differences in SAPK/MAPK phospho-protein expression in 
human esophageal samples. Phospho-protein expression following 0.1 Gy (Figure A-C) or 1 Gy (Figure D-F) 
of cesium or Fe 600 MeV/n. 
 




























































































To directly compare radiation quality effects in the human organoid samples, we graphed 
the fold expression changes relative to sham for proteins in the MAPK/SAPK pathway for both 
radiation qualities (Figure 22). Following 0.1 Gy, the expression of JNK, MSK1, STAT1, c-Jun, 
and Erk/MAPK was higher for Fe600 (22A-B). Yet, the expression of HSP27, p53, and MEK1 
was higher following 0.1 Gy Cs (Figure 22C).  Phospho-proteins ATF2 and p38 (Figure 22D) 
revealed similar expression levels between radiation qualities. At the higher 1 Gy dose, Fe 600 
MeV/n showed higher levels as compared to cesium for the majority of the phospho-proteins 
(ATF2, JNK, HSP27, p53, MEK1, MSK1, STAT1, and Erk/MAPK; Figure 6E-F). Only 
phosphoprotein p38 had a slightly greater expression following 1 Gy of cesium as compared to 
Fe600 (Figure22E). A similar expression level between the radiation qualities was observed for 








We also directly compared radiation quality effects for mouse esophageal organoids following 0.1 
Gy (Fig, 23A-C) and 1 Gy (Figure 23D-F) exposure of high vs. low LET radiation. Following the 
low 0.1 Gy dose, a higher fold expression was observed in Fe600 irradiated samples only in p38 
(Figure 23A), whereas all the remaining phospho-proteins showed either a higher expression for 
cesium (Figure 23B) or no difference between the radiation qualities (Figure 23C). Following the 
higher 1 Gy dose more phospho-proteins showed a higher expression with Fe 600 exposure 
(Figure 23D), although ATF2, MSK1 and STAT1 were higher with cesium exposure (Figure 
23E) and no difference was observed in fold between the radiation qualities for three phospho-
proteins (Figure 23F).  
B. C. 
 
Figure 23. Comparison of radiation quality differences in mouse esophageal 
MAPK/SAPK phospho-protein expression nine days post Fe600 or Cs exposure. 
Phospho-protein fold expression changes relative to sham following 0.1 Gy (Figure A-C) or 












































































































To gain further insight into how the expression of phospho-proteins differs depending upon 
species, we compared the Fe 600 MeV/n exposed mouse vs. human samples as a fold over each 
species respective control (Figure 24). In comparing results following a low 0.1 Gy exposure we 
observed only one phospho-protein, c-Jun, to be induced to a higher level in humans as compared 
to mice, with the majority of phospho-proteins more highly expressed in mice (Figure 22B). Two 
phospho-proteins, ATF2 and STAT1 showed similar levels of induction for both human and mice 
esophageal 3D organoids (Figure 22C). Following a higher 1 Gy dose, again human samples only 
showed a higher expression for a couple of phospho-proteins, ATF2 and STAT1 (Figure 22D), 
 
Figure 24. A comparison of MAPK/SAPK phospho-protein fold expression levels between human and 
mouse esophageal organoids 9 days following Fe600 MeV/n. Following a 0.1 Gy dose (A-C) or a 1 Gy (D-F) 















































































































with the majority of phospho-proteins being more highly expressed in mice (Figure 22E), and a 






  Species differences were also compared following cesium irradiation (Figure 25).  Exposure 
to the low 0.1 Gy dose resulted in all phospho-proteins showing a higher expression (Figure 25A) 




Figure 25. Comparison of SAPK/MAPK phospho-protein expression levels in esophageal organoids 
between species following cesium exposure. Graphs are plotted as a fold over each species respective control 
with graphs (A-B) showing effects 9 days post a low 0.1 Gy dose and graphs (C-E) showing expression post a 
higher 1 Gy dose.  
 






























































































level of expression between the species (Figure 25B). Following the higher 1 Gy dose, a few 
phospho-proteins showed a higher expression in human samples including Erk/MAPK, STAT-1, 
and c-Jun (Figure 25C). Nevertheless, the majority of the phospho-proteins still showed a higher 
expression for mouse samples as compared to human (Figure 25D), with only p38 revealing 
expression levels that were approximately the same between the species following a 1Gy dose of 
cesium (Figure 25E). 
 
3.4 Radiation Quality and Dose-dependent Effects on Persistence of gH2AX in Mouse 
Esophageal Organoids 
To quantitatively define persistent effects in esophageal epithelial cells following Fe 600 MeV/n 
and Cs exposure, esophageal organoids were exposed to radiation. Table 2 shows the number of 
foci positive cells compiled for each organoid and presented as a percentage of foci positive cells 





Table 2. Dose and Radiation quality dependent number of Foci positive cells per organoid 
Mouse Organoid Dose (Gy) Number of slides Average foci positive 
cells/organoid 
Fe600 MeV/n 0 Gy 















We first detailed levels of gH2AX foci in esophageal organoids following Fe600 MeV/n 
irradiation, a high LET ion that produces damage more difficult to resolve (Nickoloff et al. 2020). 
Organoids were exposed to both a low (0.1 Gy) and higher (1 Gy) dose. The percentage of γH2AX 
foci positive cells/organoid were then compiled for both doses. For the lower dose slightly fewer 
gH2AX foci positive cells were observed as compared to sham, although the difference was not 
significant (Figure 26, left). But in comparing 0.1 Gy to 1 Gy there was a slight, although non-
significant increase between these doses. Thus, a higher 1 Gy dose of high LET radiation causes a 






Organoids were also irradiated with cesium to provide a low LET comparison to the high 
LET exposure. With this exposure a dose-dependent response is observed, with even the lower 
 
Figure 26. The percentage of γH2AX positive cells in mouse 
esophageal organoids following high (left) vs. low LET 
(right) radiation. The percent of foci positive cells per 
organoid is displayed +/- SE.**p<0.004, *p<0.01 
 















































dose showing a slight, although non-significant elevation in the percentage of gH2AX foci/ 
organoid as compared to the control (Figure 27, right).  However, at the higher 1 Gy dose there 
was a significant elevation in the number of foci positive cells/organoid, revealing significant 
differences between both the sham and the 0.1 Gy dose. These results suggest more foci positive 






To directly compare between the radiation qualities, we normalized data based on each 
respective control level, plotting the percentage of gH2AX foci positive cells as a fold over their 
controls (Figure 27). This revealed again an increase in the percent of gH2AX foci/organoid at 
both doses in the Cs samples as compared to the Fe600 MeV/n samples. Epithelial cells within 
mouse organoids exposed to Cs had ~2.5 times more foci positive cells than did Fe ion exposed 
cells nine days post exposure (2.4-fold for low 0.1 Gy dose and 2.7-fold for high 1 Gy dose). 
 
Figure 27. Fold increase in gH2AX foci positive 

































3.5 Persistence of 53BP1 Foci in Mouse Esophageal Organoids 
To define how radiation quality impacts esophageal tissue, esophageal organoids were exposed to 
either Fe600 MeV/n or Cs and the average number of 53BP1 foci positive cells/organoid defined 





Focusing first on high LET Fe600 MeV/n results, we noted that mouse organoids revealed a 
dose dependent increase in the average number of foci positive cells per organoid (Figure 28, left) 
with both doses showing a fairly equal increase over control, with the 0 vs. 1 Gy comparison being 
significantly different. In contrast, cesium irradiation exhibited more of a dose response, with 
significant increases in the average number of foci positive cells between sham and both doses as 
well as between the doses. Both Fe and Cs exposures produced very similar levels of 53BP1 foci 
positive cells per organoid following the higher dose, whereas at the lower dose Cs produced less 
Table 3. Dose and Radiation quality dependent number of Foci positive cells based on surface 
area of the organoid 
Mouse 
Organoid 
Dose (Gy) Number of slides Pan stained Average 
foci/organoid 
Fe600 MeV/n 0 Gy 
17 4.50 0.55 
0.1 Gy 
58 16.65 1.37 
1 Gy 
130 15.62 1.64 
Cs 0 Gy 
91 8.50 0.83 
0.1 Gy 
52 15.63 1.11 
1 Gy 





foci positive cells per organoid than Fe. Of note as well is the elevated baseline levels in the cesium 






Conversely, in comparing radiation quality effects for the average number of pan-stained 
cells/organoid we noted some differences between radiation qualities (Figure 29). Following Fe 
ion exposure, similar to the average foci/organoid, the pattern appears to be an increase with both 
doses, but no dose response. In contrast, cesium exposed organoids showed a very different 
pattern, with the average number of pan-stained cells/organoid being significantly elevated at the 
lower dose as compared to the higher 1 Gy dose. In addition, sham is fairly high, and higher than 
high dose levels. 
 
 
Figure 28. Average number of 53BP1 foci positive cells per 
mouse esophageal organoid following different radiation quality 
exposures. The average number foci positive cells per organoid was 
quantified following Fe600 MeV/n or Cs exposure, ***p<0.0001, 
**p<0.001, *p<0.03. 
 




























































To allow a direct comparison between the radiation qualities we normalized results by providing 
the fold over the control values for each endpoint, using each respective control (Figure 30). In 
comparing average 53BP1 foci positive cells per organoid as a fold over control we note that Fe 
600 MeV/n exposed samples at both doses showed a greater number of persistent foci. For both 
Fe and Cs we additionally saw a slight increase with dose as well for foci positive cells/organoid. 
Similarly, for the average number of pan-stained cells per organoid as a fold over control we 
observed higher levels for the Fe ion exposed organoids. However, for pan-stained cells we failed 
to see a dose-dependent increase, and instead following Fe exposure we observed fairly equal 
levels between the doses, whereas following Cs exposure we saw much lower levels with the lower 
dose being slightly higher than the high dose.  
 
 
Figure 29. Average number of pan stained cells per mouse esophageal 
organoid following different radiation quality exposures. The average 
number foci pan-stained cells per organoid was quantified for Fe 600 MeV/n or 
cesium,*p<0.03, **p<0.003.  
  
 

































































3.6 gH2AX Kinetics in Human Esophageal Organotypic Cultures Following Fe 600 MeV/n 
Exposure 
 
Defining the kinetics of gH2AX change over time allows us to determine how well a tissue is 
able to cope with the initial damages induced by a particular radiation quality, in this case Fe 600 
MeV/n. The total number of cells and the percentage of gH2AX positive cells were defined for 
both the epithelial and fibroblast layers of human esophageal OTC (Table 4). Images taken were 
centered on the epithelial portion of the section; thus, less information was available for the 
fibroblast cells (fewer fibroblast cells visible in images, Table 4). Data were compiled for the 




Figure 30. Comparison of Radiation quality differences in 53BP1 
foci positive cells or pan-stained cells per mouse esophageal 
organoids following exposure. The average number of 53BP1 foci 
positive cells/organoid are shown as a fold over control levels (left). 
The average number of pan-stained cells/organoid is shown as a fold 
over control levels (right). 
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As might be expected, we observed a dose response in gH2AX positive cells in both tissue types 
(Figure 31) at all time points. However, Fibroblast cells appeared to have a greater proportion of 
foci positive cells at all time points, including sham irradiated samples. Sham levels varied for 
each cell type somewhat, becoming slightly lower over time. A pattern observed following both 
doses in the epithelial cells was a decrease at 24 hr timepoint as compared to the 2 hr time, but 
then a slight increase at the 72 hr timepoint. This was unique to the epithelial layer as fibroblast 
Table 4. Percentage of gH2AX foci positive cells in the epithelium and fibroblast 
layers of human esophageal OTC at 2, 24, and 72 hours post irradiation.  
 




Dose (Gy) % of Foci+ 
Cells 
 (# cells with 
foci/total scored) 
% of Foci+ 
Cells             
(# cells with 
foci/total scored) 
2 hours post 
irradiation  












































gH2AX levels remained fairly unchanged for each dose over the 72-hr time period, with significant 






To directly compare the kinetics between the cell types, we defined the fold over control 
for each cell type and timepoint (Table 5).  As can be observed very similar fold were exhibited 
for each cell type for each dose at 2hr. Even at 24 hr the fold over controls are still very similar for 
both cell types, with a larger difference only noted at the longest time point following the higher 
dose.  At 72 hr post exposure fibroblast have a 9-fold increase in gH2AX foci, whereas epithelial 
Figure 31. Kinetics of dose-dependent changes in the percentage of foci 
positive cells within the epithelial and fibroblast layers of the 
esophageal OTC 2, 24, and 72 hr post Fe 600 MeV/n exposure. The 
percentage of foci positive cells is shown over time for sham, 0.1 and 2 Gy 





cells have a 21-fold increase over sham values. A visual depiction of this table is shown in Figure 
32, revealing nearly identical folds at the earliest time point and a greater difference between the 






To assess whether the kinetics of repair are similar between the cells in the fibroblast and 
epithelial layers, as well as similar between doses, we defined the percent of damage observed at 
2hr that is still remaining at subsequent timepoints. Centering first on the epithelial cell layer 
(Figure 33A), we compared kinetics following a 0.1 Gy vs. a 2 Gy exposure. Both doses showed 
nearly identical patterns of decay following a low or a high dose. Interestingly, a rapid decrease in 
foci in the first 24 hours is then followed by a slight increase over the next 24hr. Approximately 
50% of the damage is repaired in the first ~24hr based on the elimination of gH2AX foci. By 72 
hr post exposure, epithelial cells within OTC samples exposed to either a low or a high dose both 
showed virtually identical levels of the percentage of foci remaining. 
 
Table 5. Fold change in ƔH2AX as compared to respective control for each timepoint 
OTC Dose (Gy) 
Cell Layer 2hr 24hr 72hr 
 0.1 2 0.1 2 0.1 2 
Epithelial 2.45 6.42 5.18 18.32 8.19 21.43 
Fibroblast 2.95 5.37 8.62 15.27 5.71 9.09 
   









Comparing repair kinetics in the fibroblast layer, we did not observe a rapid decrease in 
gH2AX foci the first 24 hr, as we had for epithelial cells, but rather levels stayed approximately 
the same for both doses (Figure 33B). Then in the next 24-hour period (between 24-72hr) we 
observed a decrease with cells exposed to the low 0.1 Gy dose showing less of a decline than cells 
exposed to the higher 2 Gy dose. Thus, it appears fibroblast cells have a delay in repair as compared 
to epithelial cells as neither dosed group decreased to 50% of 2hr levels during the 72 hr time 
period. However, samples exposed to the high dose reached a lower value at 72 hr than the samples 
exposed to a lower dose, indicating more rapid repair following a higher dose.   
 
Figure 32. Comparison of fold changes in 
gH2AX expression as compared to controls 













































To more directly compare the kinetics of repair between the two cell types, we overlayed the 
percent of foci induced at 2hr remaining at each time point for both cell types. Following the low 
dose exposure (Figure 33C) we saw a dramatic difference between the cell types at 24 hr where 
epithelial cells reduced the percent of foci positive cells dramatically, whereas fibroblast cell levels 
have virtually not changed. However, interestingly with the increase in gH2AX foci positive cells 
in the epithelial cells which occurs between 24 and 72 hr, the cells show very similar levels 
remaining based by 72 hr. 
Figure 33. Kinetics of gH2AX foci relative to amount induced at 2 hr post 
exposure for each cell type and timepoint. Epithelial (A) or fibroblast (B)  
cell gH2AX folds over control within the OTC  are shown for each dose. A 
comparison between the cell types following a low 0.1 Gy dose (C) or a higher 
























































































Performing a similar analysis and comparison in samples exposed to the 2 Gy dose, we 
observed again a more rapid removal of foci within first 24 hr in epithelial cells, whereas fibroblast 
showed little change over this period (Figure 33D). However, similar to the low dose, due to the 
increase in gH2AX foci positive cells in the epithelial cells during the 24-72 hr time period, we 






Lastly, to observe the variability in the number of foci positive cells per OTC section imaged, we 
compared this for each tissue layer (Figure 34). As might be expected at 2hr post exposure more 
 
 
Figure 34. Number of foci positive cells per OTC based on cell-type and dose. The total number of foci 
positive cells in the epithelial and fibroblast cell layers per OTC section imaged at 2, 24, and 72-hour post 0.1 
and 2 Gy Fe 600 MeV/n exposure. Epithelial results at A) 2hr, B) 24hr, and C) 72hr post irradiation. 
Fibroblast results at D) 2hr, E) 24hr, and F) 72hr post irradiation.  











































































































OTC sections had more foci positive cells as compared to the low dose or sham. However, a very 
different pattern is observed between the cell lines, with fibroblasts only having a maximum of 5 
foci positive cells at the earliest time point and higher dose (Figure 34D), and epithelial cells 
(Figure 34A) having a number of OTC with > 10 foci positive cells. At 24 hr post 2 Gy 
exposure more epithelial cells show cells with 1-5 foci positive cells and none have OTC with 
over 10 foci. Fibroblast cells within the OTC continue to reduce the number of foci positive cells 
over time, having at most 2 foci positive cells at the latest time point. In contrast, epithelial cells 
within OTC at 72 hr post irradiation show a very novel pattern whereby each dose group shows 
distinct levels of foci positive cells. For example, sham has at most only 1-foci positive cell per 
OTC section, the 0.1 Gy dose shows between 2-5 foci positive cells and the highest dose has 
between 5-12 foci positive cells, with 9/13 OTC images analyzed having 10 or greater foci 
positive cells. Examining the patterns reveals that between 24 and 72 hr the greatest change is 
observed for epithelial cells following 2 Gy, which shows more OTC sections with a large 
number of foci positive cells. 
 
3.7 53BP1 Kinetics in Human Esophageal Organotypic Cultures  
 
To better define how cell type and temporal kinetics vary for cells making up the OTC, the number 
of determined for each cell type and timepoint and presented as a percentage of the total number 







As can be observed, fewer fibroblast cells were present in each OTC image. For example, for every 
fibroblast cell counted, 6-40 times as many epithelial cells were counted in the OTC section. 
Because of this the values obtained for the fibroblast populations may not be as robust as the values 
obtained for the epithelial cells.  
Plotting the percentage of 53BP1 containing cells over time (2, 24 and 72 hr) in the 
epithelial and fibroblast cell layers of the OTC following Fe 600 MeV/n exposure revealed time 
and dose specific alterations (Figure 35).   
Table 6. Percentage of 53BP1 foci positive cells in the epithelium and 
fibroblast layer at 2, 24, and 72 hours post irradiation.  
 




Dose (Gy) % of Foci+ 
Cells 
% of Foci+ 
Cells 



















































For each cell type, as expected, we see the greatest percentage of foci positive cells 2-hour post 
the highest dose exposure (2 Gy). A dose-dependent increase in the induction of 53BP1 foci is 
noted in the epithelial layer 2-hour post irradiation, with the highest dose significantly different 
from both sham and the low dose. At all-time points, for both cell types, there was a significant 
difference between the control, and/or the lower 0.1 Gy dose as compared to 2 Gy.  At 24 and 72 
hours post exposure, we continue to observe a dose-dependent increase in foci positive cells within 
the epithelial layer with percentages of foci positive cells decreasing for each dose with increasing 
time. Although we do not have a value for the fibroblast 24 hr control sample, we note a significant 
  
 
Figure 35. Dose and time dependent changes in the percentage of foci 
positive cells within the epithelial and fibroblast layers of the esophageal 
OTC at 2, 24, and 72 hr post Fe 600 MeV/n exposure. The percentage of 
foci positive cells is shown over time for Sham, 0.1 and 2 Gy irradiated 
samples. ****p<0.0001, ***p<0.0005, **p=0.001, *p=0.002. 
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difference between the lower and higher dose at 24 hr, with the percentage of foci positive cells 





Given in Figure 35 a direct comparison cannot be made between cell types due to different 
baseline levels of foci positive cells, we instead compare cell types as a fold over their respective 
controls (Table 7). At the earliest 2 hr time point, we observe a greater fold increase for epithelial 
cells than for fibroblast cells following both the low and high dose. In fact, the fold change in 
epithelial cells at the 0.1 Gy dose was approximately equal to the fold change for the fibroblast 
cells following a 2 Gy exposure (3.67 vs. 3.65, respectively). No increase over control was noted 
at all for fibroblast cells 2 hr post the lower 0.1 Gy dose. At 24 hr post exposure the fold change 
for epithelial cells did not change drastically, but increased again at the 72 hr timepoint, especially 
following the high dose (10.54 fold at 2hr and 23.91 at 72 hr). Fibroblast folds could not be 
calculated at 24 hr due to loss of the 0 Gy sample, but also increased at the 72 hr timepoint as 
compared to the 2 hr timepoint for both the low and high doses. However, an accurate fold value 
Table 7. Fold change in 53BP1 Positive cells in each cell layer over time. 
OTC Dose (Gy) 
 0.1 2 0.1 2 0.1 2 
 2hr 24 hr  72hr**  
Epithelial 3.67 10.54 2.87 13.79 3.61 23.91 
Fibroblast 0.69 3.65 ND* ND* 10 35 
* Unable to calculate fold for Fb 24hr samples due to loss of 0 Gy sample. 





at 72 hr is not possible for either cell type as the 0 Gy control value was 0 for each at this timepoint, 






To assess whether damage in epithelial cells is eliminated at a similar rate following a low 
vs. a high dose exposure, we defined the percent of damage induced at 2hr for each dose as 100% 
and defined the percentage remaining over time (Figure 36A). The two doses show a similar trend 
with most of the damage being resolved in the first 24 hr. Interestingly, following a low dose 
 
Figure 36. The percentage of 53BP1 foci positive cells remaining relative to 
the amount induced at 2hr. Values plotted are the percentage of the 53BP1 
foci positive cells at 2hr that remain at 24 and 72 hours post a 0.1 or 2 Gy Fe  

































































































exposure damage appears to be eliminated slightly quicker than damage induced by a higher dose. 
For example, 50% of the damage induced by a 0.1 Gy dose is repaired in <24 hours, whereas 
following a 2 Gy dose 50% of damage is not resolved until closer to 72 hr.   
 When plotting a similar graph of the percentage of the damage induced at 2 hr that remains 
over time for the fibroblasts, we observed a different pattern (Figure 36B). Here we see an opposite 
trend with the low dose showing more damage persistence as compared to the high dose. Damage 
induced by the low dose exposure does not resolve as rapidly as damage induced by a higher dose 
of radiation in the fibroblast cells. Between 2-24 hours, more damage is repaired for the high dose, 
as compared to the low dose, which exhibits a slower repair time. However, at 72 hours, the % of 
damage remaining is nearly identical between the high and low doses for the fibroblast cells.  The 
half time of repair for both doses occurs at the same time of ~72 hours post exposure.  
To compare the kinetics of repair between the two cell types following an initial 0.1 Gy 
exposure, we over-lay the low dose plots for each cell type (Figure 36C) for the percentage of 
the 2 hr damage remaining over time. This comparison clearly shows a more persistent level of 
damage in the fibroblast layer as compared to the epithelial layer at the low dose (Figure 36C), 
with fibroblast cells showing very little repair (~90% of damage induced at 2 hr still remains) in 
first 24 hr, as compared to epithelial cells which have repaired >50% their damage in the first 24 
hr. At the latest timepoint analyzed (72hr) there is still a difference, with fibroblast cells having 
~50% of their damage remaining, whereas epithelial cells have ~20% of their damage remaining.   
Comparing the repair kinetics following 2 Gy irradiation between the cell types as a 
percentage of the damage induced at 2 hr still remaining in the OTC (Figure 36D), reveals very 




dose.  For both cells types 50% of the damage is repaired between 24 and 72 hours following the 











Figure 37. Number of 53BP1 foci per cell based on cell-type, dose and time post exposure. The total 
number of cells showing varying numbers of foci per cell in Epithelial and fibroblast cell layers at 2, 24, and 
72-hour post 0.1 and 2 Gy Fe 600 MeV/n exposure. Epithelial layer at A) 2, B) 24, and C) 72-hour post 




Lastly, to identify if there were differences between the cell types in terms of the number of foci 
per cell at each time and dose, we compared this for the epithelial (Figure 37A-C) and fibroblast 
(Figure 37D-F) layers of the OTC. As can be observed in the graphs, epithelial cells show a 
greater amount of foci per cell at both doses, with both cell types showing a reduction in 
numbers with time. A similar pattern of reduction is observed between the cell types; however, at 
the low dose we never observe more than 2 foci per cell at any timepoint for fibroblast, but 
observe up to 5 foci per cell at the earliest time for epithelial cells (Figure 37A-C vs. 37D-F). 
Both cell types show a greater amount of foci per cell at the higher dose as expected, although 
fibroblast cells reduce the number of foci per cell more rapidly as compared to the epithelial 













4.1 Thickening of Basal and Suprabasal Layers following Radiation 
Analysis of H&E stained sections from mouse organoids revealed a dose and radiation quality 
dependent increase in the thickness of what we have labeled the “whole cell layer” of the organoid 
(Figure 10). The whole cell layer on the H&E stained images is actually composed of both the 
basal and suprabasal layers. A significant increase in thickness of the layer was observed with 
dose, with a significant difference exhibited between the sham and 1 Gy Fe600 MeV/n exposed 
sample. Organoids exposed to low LET cesium (Cs) also revealed a very slight dose dependent 
increase in whole cell layer thickness, although this change was not significant. Given the fact that 
low LET radiation is less effective per unit dose, it is possible that with a higher dose, and/or by 
scoring an increased number of samples, a significant effect may also have been observed 
following the high dose Cs exposure.  To better define what may be causing the increased thickness 
of the “whole cell layer” additional studies will be needed. Possible explanations for the thickening 
of the whole cell layer include 1) a greater number of proliferating basal cells, 2) cells not properly 
differentiating as they move up from the basal layer, or 3) an increase in the number of stem cells. 
A possible underlying cause for the observed phenomenon may be inflammation and damage 
induced by the radiation exposure.   
Although we observed significant dose-dependent changes in the whole cell layer there 
were no significant changes observed in any of the other measurements. The basal, single cell 
layer, length of organoid, width of organoid, and size of the lumen were all not significantly 




length, and less so with the width, of organoids with radiation exposure. Again, this trend was 
slightly more prominent with high LET as compared to low LET. Although the increase was only 
slight, and did not reach statistical significance, the increases in width and length likely reflect the 
dose and radiation quality dependent increase in the thickness of the whole cell layer we observe 
following high LET. An increase in the whole cell layer corresponding to dose and radiation 
quality, would likely also be observed as an increase in the length and width of the organoid as 
well.  
A possible future direction would be to investigate if the number of cells making up sub-
layers change with dose thus resulting in the “thickening” phenotype observed within the whole 
cell layer. A Ki67 antibody, which recognizes proliferating cells, could be used to define which 
sub layer(s) are actively proliferating. As there is not a good stem cell marker for esophageal tissue, 
these studies would at least allow us to define if there are a greater number of proliferating basal 
cells, and to define if they are differentiating by using markers specific for the sub-layers. 
 
4.2 Dose-response of MAPK/SAPK Signaling in Mouse Esophageal Organoids in Response 
to Fe 600 MeV/n Exposure 
These studies were performed to decipher how esophageal tissue, mimicked by using 3D 
organoid cultures, may respond uniquely to a low (0.1 Gy) vs. a higher dose (1 Gy) of Fe 600 
MeV/u radiation and the role of the TGFb and ATM pathways in this response. In particular, we 
wanted to define whether there was cross-talk between the TGFb and ATM pathways and 
whether this cross-talk was regulated differently depending on dose. We focused on the stress 
pathway as this is a pathway known to be important in responding to environmental exposures, 




Looking at expression patterns in the stress pathway without added inhibitors, we observe 
some unique trends with some phospho-proteins 24 hours after exposure. An increase in 
expression at the low dose and decrease in expression following the higher dose was observed 
with Erk/MAPK, p53 and MEK1. It is also of interest that these same phospho-proteins are 
increased to a greater degree at a low 0.1 Gy dose than a higher dose. Although no expression 
levels were significantly different between these doses and sham, the pattern of change may 
indicate novel dose-dependent regulation of these phospho-proteins. The pattern observed with 
Erk/MAPK phosphorylation fits well with previous data showing that low levels of DSBs can 
activate ERK pro-survival signaling causing an increase in cell proliferation, whereas higher 
levels instead result in ERK dephosphorylation Khalil et al. 2011). The authors of this latter 
paper suggested that this shift in pattern is consistent with a dose-dependent switch from a pro-
survival state to anti-survival state, although the doses they had considered were higher than 
those in the current work. Another study also partially supports our findings as it indicates that 
stress-activated kinases are activated by very low doses (0.1 Gy) of ionizing radiation, but 
indicates that ERK2 shows a progressive increase in expression with dose, until 3 Gy, at which 
point it shows a marginal decline (Narang and Krishna 2004). In the present study we noted a 
decrease at a 1 Gy dose, which is below the 3 Gy dose that a decrease in expression was noted in 
this previous work. This discrepancy perhaps indicates that tissue type or species may play a role 
in activation as Narang and Krishna used rat liver tissue and the present study used human 
esophageal cells. One phospho-protein also appeared to show a dose dependent decrease, p38, 
indicating its expression may be down-regulated with increasing dose, implying perhaps a 




To define the role of ATM, an important key kinase involved in both sensing and 
responding to radiation damage (Marechal and Zou 2013), we added ATM inhibitor to the 
samples and defined the expression pattern of stress pathway phospho-proteins as compared to 
control or dose alone samples (Figure 13). Most phospho-proteins either with no dose or low 
doses showed a trend to decrease in expression with ATM inhibition, indicating ATM’s normal 
function at no and low doses is to aid in increasing the phosphorylation of these proteins. 
Significant decreases were noted in 0Gy irradiated samples with Hsp27 and p38 (Figure 13A) 
with ATMi. Also, following a low 0.1 Gy dose p53 expression was significantly decreased 
(Figure 13C). This indicates ATM is perhaps specifically important in regulating Hsp27, p38, 
and p53 at no and low doses.  Fewer phospho-proteins showed a decrease in expression with a 
higher dose, only ATF2, Hsp27 and Stat1 (Figure 13F) decreased in expression, with ATF2 
showing a significant decrease in expression following a 1 Gy dose +ATM inhibition as 
compared to the 1 Gy sample. A dose-dependent decrease in ATF2 expression was also uniquely 
observed with ATM inhibition, indicating that ATM is especially important in regulating the 
expression of ATF2, and that with increasing radiation exposure ATM plays a larger role. This is 
somewhat unexpected as the phospho-site that is captured in this assay is Thr71, not Ser 490/98, 
the phospho-site on ATF2 which is known to be regulated by ATM following DNA damage. 
Thr71 is phosphorylated to regulate ATF2’s function as a transcription factor (Ouwens et al. 
2002) and JNK, p38 or ERK1 are known to phosphorylate it at this particular site.  This ATM-
dependent decrease in ATF2 Thr71 expression; however, could be explained by the fact that 
ERK has also been shown to be modulated by the addition of the ATM inhibitor, KU-55933 and 
ERK phosphorylation dependent on ATM (Bhoumik et al. 2005). Thus, the effect on ATF2 




studies assaying the Thr71 and Ser 490/98 phospho-sites following radiation in ATM defective 
cells would be important to clarify this. Previous work has also suggested that if ATF2 is 
phosphorylated on Thr71 it cannot function in its role in DNA damage, as the two sites are 
phosphorylated mutually exclusively (Bhoumik et al. 2005). However, in response to severe 
and/or sustained stress as caused by ionizing radiation, a portion of nuclear ATF2 is exported 
from the nucleus and accumulates in the cytoplasm (Lau and Ronai 2012)(Lau and Ronai 
2012)(Lau and Ronai 2012)(Lau and Ronai 2012)(Lau and Ronai 2012)(Lau and Ronai 2012) 
(Lau and Ronai 2012), thus it is likely that pools of ATF2 are phosphorylated uniquely on Thr71 
vs. Ser490/98 and show differential localization following various dose exposures. 
We next defined how added levels of TGFβ may impact the expression of phospho-
proteins in the stress pathway at a low vs. higher dose. TGFβ is expressed in tissues following 
radiation, both in fibroblast cells within the basement membrane as well as at lower levels in the 
epithelial cells themselves (Mauviel 2009, Wang et al. 2012). Thus, results observed are due to 
the added TGFβ, in addition to that which may be expressed by these cells following the 
radiation exposure. In general, the addition of TGFβ appeared to lower levels of all phospho-
proteins independent of dose. Thus, higher levels of TGFβ likely play a role in decreasing the 
expression of these stress response proteins. This fits well with previous work noting that TGFβ 
is a key regulator of cell proliferation, and in normal tissues its role is to decrease proliferation 
(Kurokowa et al. 1987, Kubiczkova et al. 2012). 
To gain further insight into the role of TGFβ, we used a specific inhibitor to decrease the 
endogenous or exposure-induced level of TGFβ. Following a sham or low dose, we observed 
that the majority of all phospho-protein expressions decreased (Figure 15A and D) or remained 




following a low dose. Based on results using the inhibitor it would seem that TGFβ is important 
(at normal levels) in increasing phospho-protein expression levels following no/low doses. This 
is in contrast to what we observed with the addition of TGFβ, but it must be emphasized that 
there are differing responses to TGFβ depending on the level of its expression. It is likely that at 
its normal level in the cell it aids in supporting proliferation with no/low doses, whereas at a 
higher level in the cell has an opposite effect. Moving up to a higher dose there are fewer 
phospho-proteins showing a decrease in expression, with Erk/MAPk and cJun now showing an 
increase, indicating TGFβ would inhibit their expression following a 1 Gy dose.  
Of particular interest with the addition of TGFb was the dose-dependent increase in 
expression of HSP27, and dose-dependent decrease in expression with TGFb inhibition (Figure 
15J), although results were not significant different. These results suggest a role for TGFb in 
regulating Hsp27. Our findings are also supported by previous studies in mice noting that the 
expression of HSP27 is upregulated in lung tissue and fibroblasts of mice treated with the 
radiomimetic, BLM (Wang et al. 2017). They also showed that TGFβ-induced HSP27 expression 
and that this was both Smad3- and NFκB-dependent. Lastly, they observed that depleting HSP27 
partially inhibited the activation of Smad3 and ERK, indicating a feedback loop between HSP27 
and TGFb. Our findings add to this previous work in defining that TGFb modifies HSP27 levels 
in a dose-dependent manner.  
  To better identify if the ATM and TGFβ co-regulate some stress phospho-protein 
expressions, we added both ATM and TGFβ inhibitors to the cells and studied response with low 
vs. high doses. Similar to the pattern observed following ATM inhibitor alone or TGFβ inhibitor 
alone most phospho-proteins with no or low doses showed a trend of decreasing expression. 




fewer phospho-proteins showing a decrease (compare Figure 16 E & F versus 16A and C). 
Also, of interest Hsp27 shows the opposite pattern of increasing with dose when both inhibitors 
are added unlike the decrease noted with TGFb inhibitor alone. This unique dose-dependent 
pattern would indicate that ATM plays some role in modulating Hsp27 phospho-protein 
expression in coordination with TGFb, and that the modulation is dose-dependent.  
Another protein showing a dose-dependent expression pattern only in the presence of 
both inhibitors was MSK1. With TGFb inhibitor addition MSK1 had not shown an expression 
change in the sham or following 1 Gy dose exposure, and only a slight decrease following the 
low dose. However, in the presence of both inhibitors, it shows a dose-dependent decrease.  
Thus, MSK1 expression also appears to be regulated in a dose-dependent manner by ATM and 
TGFb. MSK1 activity is tightly regulated in cells, and its activation requires first 
phosphorylation by either ERK1/2 or p38 at other MSK1 sites. Following this, activation of the 
c-terminal kinase domain occurs, which then leads to auto phosphorylation of further sites in 
MSK1, such as the Ser 212 site (McCoy et al. 2007), the site studied in this work. This would 
imply that one or more initial phosphorylation site(s) leading to its autophosphorylation are 
controlled in part by both the ATM and TGFb pathways, but further work would be needed to 
completely define which sites are coordinately regulated. 
To further uncover potential cross talk between the ATM and TGFβ pathways we 
focused on unique responses observed in the presence of both inhibitors, that were not observed 
in the presence of either inhibitor alone (Figure 17 and Table 1). In this comparison we were 
able to identify some phospho-proteins which maybe dually regulated by both pathways 
including MEK1 (at no and low dose), JNK (at no and high dose), c-Jun (only in sham), p53 (at 




1 (only at a low dose). The rest of the phospho-proteins appeared to show similar responses in 
terms of expression levels to either one of the single inhibitors alone. A complete overview of all 
previous studies noting a role of ATM and /or TGFb in the expression of each of these phospho-
sites we predict to be uniquely co-regulated is beyond the scope of this paper. However, 
centering on one phospho-protein, p53 Ser15, there is evidence in the literature that both ATM and 
TGFb regulate this phospho-site, although not specifically in a combined manner. For example, 
ROS-dependent mechanisms initiated by TGFb were noted to be essential for p53Ser15 
phosphorylation (Samarakoon et al. 2013) and ATM has been shown to be key in localizing p53 
to mitotic centrosomes, with phosphorylation at Ser15 playing a critical role (Tritarelli et al. 
2004). The findings from this work will provide fodder for subsequent studies investigating the 
combined role of both pathways in regulating the expression of these stress pathway phospho-
proteins following radiation. 
In summary, this work indicates that unique responses are initiated in response to a low 
vs. a high dose of radiation, with Erk/MAPK, p53 and MSK1 phospho-sites showing an increase 
at a low dose and a decrease at a high dose. Interestingly, p53 has been shown to induce cell 
cycle arrest and apoptosis, whereas ERK1/2 to promote cell growth (Suzuki et al. 2001), thus 
even phospho-proteins showing a similar regulation with dose may have diverse effects on cells. 
This work also clearly indicates that a number of phospho-sites in the stress pathway appear to 
be regulated by cross-talk between the ATM and TGFβ pathways, and that different phospho-
proteins/sites are regulated uniquely based on dose. Further studies will be needed to dissect the 
exact upstream and downstream role of TGFb and ATM, but this work provides important initial 





4.3 Comparison of SAPK/MAPK Phospho-Protein Response in Human and Mouse 
Esophageal Organoids Following Different Radiation Qualities  
This study was designed to reveal how the MAPK/SAPK stress pathway phospho-protein 
expression differs in esophageal tissue based on dose, radiation quality or species. The work was 
also intended to better understand persistent effects by studying samples nine days post exposure. 
Stress pathways are induced following environmental effects, including radiation, and 
investigating more persistent effects may allow us to better understand changes following 
radiation damage that may contribute to cancer development years post exposure.  
Mitogen-activated protein kinases (MAPK) are conserved between most species and play 
a role in mediating and increasing growth factor signals from the cytoplasm to the nucleus (Dent 
et al. 2003). Three major MAPK pathways have been described, including: the extracellular 
signal-related kinase (ERK (Dent et al. 2003)); the c-Jun NH2-terminal kinase (JNK) (Raivich 
2008); and the p38 MAPK pathways  (Sherman et al. 1990) (Figure 5). These pathways are key 
in regulating normal cell growth, and are turned on in response to environmental stresses such as 
ionizing radiation (IR). The pathways work together to ensure that cell death, growth, and 
survival are properly balanced. Typically, studies have shown that JNK and p38 are associated 
with apoptosis, whereas the ERK pathway is principally tied to cell proliferation, survival and 
the prevention of apoptosis. 
There were three major questions we were attempting to address, including whether there 
are dose dependent changes, radiation quality or species-specific differences in stress-phospho-
protein expression. This work has revealed some similarities as well as differences, and we will 




In comparing dose-dependent similarities or differences, both radiation qualities and 
species revealed a significant and dramatic increase in c-Jun phosphorylation following the low 
0.1 Gy dose, and a lower increase following a higher dose of 1 Gy, indicating a decrease in the 
activity of this protein at a higher dose (compare Figure 18A/19A and 18E/19E). 
Phosphorylation of c-Jun at Ser73 has typically been linked to enhanced transcriptional activity 
(Raivich 2008) with JNK being the primary kinase responsible for this activation. However, 
other MAPKs, including p38 and Erk/MAPK have also been shown to regulate c-Jun 
phosphorylation depending on the cellular processes, with the specific kinase likely dependent 
on cell type and/or the cellular context. However, following a low dose of high LET exposure 
neither JNK, p38 or Erk/MAPK were similarly elevated at this timepoint, and in fact showed 
lower levels as compared to control, with Erk/MAPK being significantly lower. Given we have 
only defined the expression nine days post exposure, just a window in time, we are unable to 
discern if perhaps one of these upstream kinases was elevated at an earlier timepoint and then 
subsequently down regulated, perhaps in a feedback type of mechanism. Studies have shown that 
c-Jun Ser73 phosphorylation can be stimulated by proinflammatory factors, and that 
accumulation of these proinflammatory factors modulate c-Jun phosphorylation and activation. 
Although previous studies have also shown c-Jun to be regulated by ionizing radiation, most 
studies to date have not centered on very low doses as we have in this work, and also typically 
define total c-Jun levels, rather than specific activation at this phospho-site. For example, c-Jun 
RNA levels were shown to exhibit a dose dependent increase in HL-60 promyelocytic leukemia 
cells, with levels being virtually non-existent at the lowest dose of 2 Gy on a Northern blot 
(Sherman et al. 1990). They also noted a dose rate-dependent difference, whereby lowering the 




underlying this finding. Thus, our finding showing c-Jun to be significantly increased at such a 
low dose, but not at a higher 1 Gy dose, both with high and low LET radiation, is unique and 
requires further investigation. 
Another dose-specific response observed following Fe 600 MeV/n exposure is the 
increase in expression at the high dose and decrease in expression at the low dose of Erk/MAPK, 
as compared to sham (Figure 18K). Thus, an opposite expression pattern is observed with dose. 
Other work has also shown a complex association between dose and phosphorylation.  Very low 
doses of X-ray between 2-5 cGy were shown to stimulate proliferation of normal human diploid 
cells, whereas higher doses (>1 Gy) caused a decrease in Erk/MAPK phosphorylation (Suzuki et 
al. 2001). Additional work, in mesenchymal stem cells isolated from rats and cultured in vitro, 
has shown phosphorylated ERK1/2 to be significantly increased with radiation exposure peaking 
~6 h after exposure to 0.75 cGy X-rays (Liang et al. 2011). The latter study noted a dose-
dependent increase from 0.2 to 0.75 cGy and decrease at 1 cGy. These doses are significantly 
lower than what we have used in the current work, but suggest that different dose ranges have 
specific multi-modal regulation, likely also differing depending on the time post exposure.  
It is important, as most radiation studies have been performed using low LET radiation, 
and radiotherapy is moving to conformal types of therapy such as carbon ion, to discern if high 
LET radiation causes unique stress pathway expression patterns. In addition, it is likely that 
responses differ depending on the dose. Some responses more specific to high LET include the 
increase in expression of HSP27 and p53 following the higher 1 Gy dose in human cells. Mouse 
cells also exhibit a difference between radiation qualities with p38 and Erk/MAPK significantly 
elevated following a 1 Gy dose of Fe but not Cs. Directly comparing expression levels for each 




phospho-proteins showing higher levels of expression following high LET for both doses. 
Whereas mouse cells had a greater number of phospho-proteins showing higher expression 
following the low LET radiation exposure, although more so following the low as opposed to the 
high dose. Given high LET ions are more biologically effective per unit dose, one might expect 
less expression induced at the low dose as at this dose not all of the cells are transversed by the 
radiation (~60%). However, chronic ROS and bystander effects could cause additional effects in 
neighboring cells. Our results imply humans elicit a more persistent response to high LET, even 
at low doses, as compared to low LET. Whereas mouse cells at a low dose elicit more of a 
response with low LET exposure, and only at a high dose does Fe irradiation cause a more 
persistent and larger effect.  
Another observation following both Fe and Cs irradiation is that in mice nearly all the 
phospho-proteins remain elevated, especially following the low 0.1 Gy dose (Figure 20A, B and 
Figure 21A, B). This result appears to suggest (An et al. 2013)absent in murine cells, partially 
functional in chicken cells and fully functional in human cells. However, survival curves did not 
appear to relate to levels of SSB repair. Additionally, potentially lethal damage (PLD) repair was 
more proficient in both human and chicken cells as compared to murine cells, which may relate 
in part to the differing sensitivities observed. What appears evident from our results is that there 
is a difference between the expression of phospho-proteins following radiation between mouse 
and humans, and in some cases opposite effects are observed. In addition, Erk/MAPK is also 
uniquely regulated in mouse vs. humans, being significantly elevated in humans and unchanged 
in mice. However, there are some commonalities, for example ATF2, STAT1, and c-Jun all 
show an increase in expression in both species following the low dose exposure. Another major 




perhaps less importance in dealing with environmental exposures. In general, there appear to be 
some conserved responses between the species, but for most phospho-proteins unique responses 
are observed and this fact should be of concern in extrapolating results from mouse to human. 
In summary, some unique and conserved findings were observed comparing radiation 
quality and species SAPK/MAPK phospho-protein expression levels nine days post a low vs. 
high dose (Table 8). c-Jun was unique in being increased in nearly all situations, both at the low 
and high dose, with both radiation qualities and within both species. Other increases or decreases 
appear to be specific to either the species or radiation quality. Thus, caution should be used in 
generalizing these results either between radiation qualities or between mouse and human results. 
This study also points out the importance of performing time course studies to better define 
relationships between signaling nodes. However, this study provides preliminary data on 
persistent levels of stress pathway activation based on dose, radiation-quality, and species to 








4.4 Radiation Quality and Dose-dependent Effects on Persistence of gH2AX in Mouse 
Esophageal Organoids 
The purpose of the radiation quality and dose-dependent effects on Persistence of gH2AX in 
Mouse Esophageal Organoids study was to define whether different radiation qualities cause 
unique and persistent damage in exposed esophageal tissue. Radiation-induced foci (RIF) were 
quantified using gH2AX, a marker typically associated with double strand breaks (DSB). 
Observing higher levels of gH2AX nine days following a particular radiation quality will allow us 
to speculate if a given radiation quality has a greater propensity to induce genomic instability in 
exposed esophageal tissue. Most studies to date have noted that DNA damage foci are typically 
resolved within hours of the exposure at the doses used in this study, with slightly more remaining 
up to 24 hr following the higher 1 Gy dose (Mariotti et al. 2013). However, foci evident at many 
days post exposure have also been linked to Reactive oxygen species (ROS). ROS is induced 
Table 8. Phospho-proteins showing significant increases or decreases depending on 
species, radiation quality or dose. Compilation of phospho-protein expressions that were 
either significantly increased or decreased from sham, p<0.05 for each species and radiation 
quality.  
Increase 0.1 Gy 1 Gy 
Fe 600 c-Jun ATF2, p53, Erk/MAPK 
Cs c-Jun JNK 
M-Fe ATF2, p53, MEK1, JNK p53, MEK1, MSK1, p38, Erk/MAPK, JNK 
M-Cs c-Jun, ATF2, p53, MEK1, MSK1 ATF2, p53, MEK1, MSK1, JNK 
      
Decrease 0.1 Gy 1 Gy 
Fe 600 Erk/MAPK None 
Cs Erk/MAPk JNK 
M-Fe 600 None None 






immediately following radiation, but is thought to be further induced due to unrepaired damage, 
which stimulates additional ROS levels, and oxidative stress within the cells.  This increase in 
ROS and oxidative stress in turn result in even more DSBs (Sridharan et al. 2015). It is thought 
that this chronic ROS may lead to a greater susceptibility to cancer at much later times (years) post 
exposure. In these studies organoids were seeded a day prior to radiation and fixed nine days post 
exposure when organoids were fully formed. Thus, only the initial parental cells used to seed the 
organoids were damaged by the radiation and yet presumably a number of the daughter cells have 
acquired gH2AX foci during the nine-day period following radiation. Given only the initially 
seeded cells were directly irradiated, the finding of a much greater proportion of cells exhibiting 
foci suggests these directly irradiated cells must somehow cause gH2AX foci in the daughter cells. 
A possible mechanism for this could be through ROS emitted into the medium by the directly 
irradiated cells. Alternatively, Ricoul et al. has shown that persistent gH2AX foci can be observed 
at the sites of misrepaired lesions (Ricoul et al. 2019). This would suggest that cells containing 
chromosome aberrations were transferred to the daughter cells, again resulting in an overall 
persistent elevation in gH2AX foci within the esophageal organoid tissue, generations post the 
exposure. 
Surprisingly, although it would be expected that Fe 600 MeV/n induces more damage per 
Gy, and thus perhaps have more persistent foci, our work shows lower levels of persistent foci at 
each dose for Fe 600 MeV/n as compared to cesium (Figure 26). At the low dose this could be 
explained by the fact that only ~60% of the initially seeded cells are transversed by a particle, 
whereas at the higher 1 Gy dose all the seeded cells would be expected to have been hit during 
the initial exposure. Thus, the rationale could not explain the lower levels observed at a higher 




the greater effectiveness of high LET ions in producing more complex damage per unit dose, 
which is more difficult to repair (Niemantsverdriet et al. 2012), a possible explanation for the 
lowered levels of gH2AX foci positive cells following Fe ion exposure as compared to cesium is 
that there are fewer surviving cells left to divide and form the organoids, which are then scored 
for foci positive cells 9 days post exposure. However, another by Chevalier et al.study 
comparing radiation quality effects using 3D organoid cultures did not see similar radiation 
quality effects (2019). Work done using a 3D chondrosarcoma model show that high-LET 
radiation (Carbon 95 MeV/n, 2 Gy) produced higher and more persistent foci as compared to 
low-LET (X-ray) exposure (Chevalier et al. 2019). Obviously, these results are not consistent 
with our findings, but the difference in results could be explained by a number of divergences 
between these studies. The studies differed in: tissue type, final time point, dose, method of 
gH2AX detection, and type of high LET radiation exposure. Thus, additional time course studies 
using our model defining gH2AX foci and the level of apoptosis would be needed to determine 
whether our speculation is correct. 
We speculate the results suggest that Fe ions may induce more deadly insults leading to 
the elimination of cells in actively growing cultures, whereas cesium exposure may allow cells to 
survive, due to the lower level of damage, resulting in gnomically unstable daughter cells. Whether 
the ability to survive leads to a greater risk of cancer in the long term, is speculative, but further 
time course 3D tissue and animal studies may help to resolve this.  
 
4.5 Radiation Quality and Dose-dependent Effects on Persistence of 53BP1 Foci in Mouse 
Esophageal Organoids 
 
This study was designed to determine if there are radiation quality and dose-dependent 




Mouse organoid cultures were exposed to a high LET radiation, Fe600 MeV/n, and a low LET 
radiation Cesium, at either a low 0.1 Gy or higher 1 Gy dose. The three-dimensional (3D) mouse 
esophageal organoid model was used to mimic actual esophageal tissue and fixed nine days post 
irradiation to investigate persistent effects. Organoids were seeded a day prior to irradiation, to 
then define the effects of irradiation on a growing tissue. Organoids were fixed and sectioned 
after 10 days of growth and stained for 53BP1 foci. 53BP1 is typically used at early times post 
exposure as a marker of DNA double strand breaks. Conversely, at longer times post exposure 
these foci may also represent senescence-associated heterochromatin foci (SAHF). Senescent 
cells can be induced by ionizing radiation and have been shown to stain positively for 53BP1 
foci which co-localize with gH2AX foci (Minieri et al. 2015).  
In comparing the number of 53BP1 positive cells per organoid between radiation 
qualities we observe slightly higher numbers following Fe ion exposure than for cesium at the 
lower dose. Whereas at the higher dose levels of foci are fairly similar (Figure 28). As baseline 
levels were much higher in the cesium irradiated cells, we graphed each endpoint as a fold over 
control. In doing so we observe Fe ion exposed organoids to show greater levels of cells 
containing foci and pan-staining at both doses (Figure 30).  Compared to the majority of foci 
studies which have been done previously, nine days post exposure is a fairly long time period 
after radiation to quantify foci, thus there are no other 3D studies that we are aware of that we 
can directly compare to at this timepoint. However, studies have shown Fe ions to be typically 
more biologically effective and produce more lasting damage (Wang et al. 2012), which would 
agree with our findings.  
Although no other esophageal 3D tissue culture models have studied radiation quality 




differences in 3D skin models up to 72 hr post exposure (von Neubeck et al. 2015). This work 
revealed that radiation quality differences were more important in predicting detrimental 
biological effects (proliferation and differentiation) than was dose (von Neubeck et al. 2015). 
However, a number of differences exist between these studies including: a different type of 
radiation exposure, different cell type, different endpoints and time point. It is of interest that 
induced proliferation and differentiation was observed to a greater degree specifically in high 
LET exposed samples.  
Other researchers have attempted to better understand what persistent damage in cells 
may correspond to. For example, standard monocultures were used to investigate persistent 
DSBs up to a month post exposure. Nine different cell lines were used by Dikomey et al.to detail 
the relationship between radiosensitivity and persistent double-strand breaks (as measured by 
pulse field) (1998). This work revealed residual DSB to be a fairly good predictor of 
radiosensitivity (Dikomey et al. 1998). If the residual foci measured in our assay accurately 
reflect unrepaired DSB 9 days post exposure, our results would suggest that Fe 600 MeV/u 
exposure is more detrimental to esophageal tissues than is Cs exposure. Unfortunately, 
confirmation of DSB by another method would be needed to verify this.  
It is also possible that the foci mark senescent cells, although typical doses that result in 
senescent cells are much higher (>6 Gy X-ray). In any respect, levels of unrepairable DSBs have 
been used to identify individuals at greater risk for developing the adverse effects associated with 
radiotherapy (Noda 2018). Thus, whatever the underlying reason for the higher levels of 
persistent foci, we might speculate that our results may indicate that esophageal tissue is 
radiosensitive and that Fe is more damaging than Cs to this tissue. Comparison with other 3D 




It is uncertain what 53BP1 pan-stained cells represent at these late time points, as typically total 
53BP1 is found throughout the cell and just relocalizes to DSB after damage. However, pan-
stained gH2AX cells have been noted and associated with replication stress (Moeglin et al. 2019) 
and although 53BP1 has not been studied in this context, it has been shown in normal cells to co-
localize with gH2AX during S phase (Harding and Bristow 2012). Thus, these cells could be 
defining cells in S phase and possibly cells experiencing some replication stress as well. Given 
the dosed samples show more elevated levels, it may reflect replication stress. In addition, work 
has shown that low and high-LET radiation increase ROS levels, but the induction is 
independent of radiation quality and dose (Werner et al. 2014), which is what we appear to see 
for the 53BP1 pan staining phenotype. It is of interest that for cesium the lower dose appears to 
experience far greater effects, and the reason for this is uncertain. Further studies would be 
needed to define if ROS levels and oxidative stress were responsible for the elevated pan-stained 
53BP1 signal in the esophageal organoids. 
In summary, this work reveals a radiation quality difference in persistent 53BP1 foci within 
the esophageal tissue, indicating Fe600 MeV/n to be more damaging than cesium. It also hints 
toward some non-radiation quality dependent increases in ROS that may lead to increased 
oxidative stress and damage in long-term radiation-exposed esophageal tissue. Future more 
detailed and multi-endpoint (senescence, ROS levels, cell cycle) time course studies would be 
needed to confirm these results. 
 
4.6 gH2AX Kinetics in Human Esophageal Organotypic Cultures Following  
Fe 600 MeV/n Exposure  
gH2AX radiation induced foci (RIF) have been used in a large number of studies to define levels 




(Rogakou et al. 1998). gH2AX, at least at early times post repair have been shown to provide a 
fairly good correlation to the number of DSBs (Lobrich et al. 2010). In this study we strove to 
define the sensitivity of esophageal tissue to Fe 600 MeV/n exposure by quantifying gH2AX foci 
at various times post exposure using a human esophageal organotypic model and establishing the 
kinetics of induction and repair. Both a low, 0.1 Gy, and a higher, 2 Gy, dose were used and 
samples collected at 2, 24 and 72 hr post exposure. Human esophageal organotypic 3D cultures 
were used in an attempt to more closely mimic actual human esophageal tissue. As esophageal 
organotypic cultures contain both fibroblast and epithelial cells this also allows foci kinetics for 
the two cell types to be defined as well. 
Predictably, a dose-dependent increase in gH2AX foci was observed at 2 hr for both cell 
types, however, differences were not significant except in the fibroblast cells which showed 
significant differences between the sham and the 2 Gy samples at all timepoints (Figure 31). It is 
evident from the comparison between the cell types that epithelial cells appear to induce fewer foci 
positive cells as compared to fibroblasts, but one caveat to the analysis was the much lower total 
numbers of cells that could be scored in the fibroblast layer (Table 5), as images did not include 
much of this layer, which likely limits the robustness of the findings. Larger studies focusing 
specifically on the underlying fibroblast layer would be needed to verify the differences observed 
between these cell types.  
It is difficult to directly compare the kinetics of removal we observed with other studies as 
typically they present foci per cell or total fluorescence per cell, which we did not define in this 
work. In addition, the majority of other studies have not been done using 3D tissue models. But in 
comparing results from another study looking at the rate of foci loss per cell over time in fibroblasts 




et al. (Lobrich et al. 2010). This is similar to what we observed at 24 hr for the epithelial cells, but 
not the fibroblast cells. Besides the fewer cells scored in the fibroblast layer, this difference could 
also be due to a number of other reasons. For example, it is possible that high LET, as opposed to 
low LET X-ray, causes more of a delay in damage resolution in fibroblasts. This is suggested in 
work by Sridharan et al., which measured gH2AX intensity per cell by flow cytometry in 
fibroblasts, and revealed a maximal induction of gH2AX foci at 2 hr post exposure following Fe 
ion exposure whereas following X-ray maximum levels were noted at the earliest timepoint 
measured, 0.5 hr (2020).  However, if this was the case one would expect foci positive cells to 
decrease following 2 hr rather than at 72 hr post exposure as was observed. Therefore, the 
difference in our study with previous work may have to do more with our tissues being exposed in 
a 3D rather than a 2D context.  
 Previous work studying gH2AX kinetics in human mammary epithelial cells, in both a 
2D and 3D context, noted that if the cells were not proliferating, foci were still present 72 hr post 
exposure (Groesser et al. 2011). However, if they were proliferating, either in 2D or 3D context, 
they decreased to control levels by 24 to 48 hours. Typically, in the fibroblast layer there is no 
further proliferation occurring following the OTC seeding. However, epithelial cells may 
continue to proliferate, and based on this previous work, this would allow the cells to resolve 
damages.  
An especially unexpected and peculiar finding of this study was the lowered levels of foci 
positive cells at 24 hr and increase at 72 hr observed in the epithelial cells. Possible explanations 
for this finding include, an increase in foci positive cells due to misrepair of the induced 
damages, which might show up at this later time point, particularly at the higher dose. This is 




chromosome aberrations (Ricoul et al. 2019). Or alternatively, unresolved damage has been 
shown to increase ROS, which in turn increases DNA damage and this could be specifically 
occurring more prominently in the epithelial cell layer (Sridharan et al. 2015). Further time 
course studies defining levels of misrepair and /or ROS levels in the OTC cultures would be 
needed to resolve this. 
In conclusion, the study provides evidence of a cell type, but not dose-dependent, 
difference in resolution of gH2AX foci in a 3D tissue context. In addition, based on prior gH2AX 
work (Mariotti et al. 2013) following low LET radiation more persistent effects are suggested 
following high LET, although a direct comparison in this model system would be needed to 
confirm this.  Overall, the persistent levels of foci positive cells at late times in the esophageal 
OTC may indicate severe consequences such as chromosome aberrations, or genomic instability, 
and suggest Fe 600 MeV/u exposure may have lasting ramifications on this tissue in vivo and 
increase the potential of cancer development. 
 
4.7 53BP1 Kinetics in Human Esophageal Organotypic Cultures Following Fe 600 MeV/n 
Exposure 
Epithelial and fibroblast cells within the OTC were scored separately to define whether 
differences in radiation sensitivity exist between the two cell types even when exposed as part of 
the same 3D tissue construct. These studies reveal that different cell types, even within the same 
tissue, can show unique DNA damage kinetics following radiation exposure (Figure 36). For 
example, 2 hr post exposure fibroblast cells fail to show an increase over control for the low dose 
exposure and exhibit only a ~3.6-fold increase following a larger 2 Gy exposure. This is very 
different from the epithelial cells which show a 3.6-fold increase over controls at the low dose and 




However, the differences between the cell types also appear to be dose specific. Fibroblast 
cells exhibit a lower number of foci positive cells at 2 hr and a slower resolution of damage 
following the low dose exposure, which is different from what is observed following the higher 2 
Gy dose (Figure 36C vs. 36D). This pattern of response is opposite from what is observed in 
epithelial cells, where a faster repair following the low dose is detected. However, following the 
higher dose, we observe a more similar response between the cell types (Figure 36D). It may make 
sense following a high dose for the repair to take longer due to greater numbers of complex double 
strand breaks being a larger component of the total damage induced. However, if this is the case 
then only the epithelial cells exhibit the expected pattern whereby damage is repaired more rapidly 
following a lower vs. a higher dose. 
Our findings indicate that fibroblast cells fail to induce a very robust response at low 
doses yet are slow to repair as compared to epithelial cells (Figure 36A vs. 36B). A similar 
delayed repair response for fibroblast was observed by Lobrich and colleagues using primary 
human fibroblasts cells (Rothkamm and Lobrich 2003, Grudzenski et al. 2010). They observed 
that fibroblast cells were able to repair a single DSB proficiently if the break was induced with 
doses between 40–80 mGy (0.04-0.08 Gy), yet failed to repair damage induced by a very low 10 
mGy (0.01 Gy) dose, and that damage induced by this dose remained unrepaired for up 72 hours 
post irradiation (Rothkamm and Lobrich 2003, Grudzenski et al. 2010).  Thus, although these 
researchers did observe a delay following a low vs. a higher dose, their low dose was much 
lower than ours. Based on their studies done using 2D monocultures we would have expected our 
low dose damage in fibroblasts to repair with normal kinetics, as the low dose we used (0.1 Gy) 
is similar to their 80 mGy dose, which did show efficient repair. In addition, the rationale 




damage is needed to activate the repair mechanisms and that below this level cells are unable to 
repair DSBs (Rothkamm and Lobrich 2003). However, it is possible that there is a dose-
dependent resolution of repair occurring within the dose range we used as well, with repair being 
slower following the low vs. the higher dose. In addition, a number of differences exist between 
our study the Rothkamm and Lobrich., including our use of high LET radiation and exposure in 
3D vs. 2D (2003). Further 3D OTC studies including more robust numbers of fibroblast cells 
would be needed to confirm our findings.  
Another possible explanation for the unique difference between cell types following the 
low vs. higher dose exposure is perhaps differences in the cells response to bystander induced 
damages. Following the low Fe600 MeV/n dose, only 35% of cells are hit, with an average hit per 
cell of 0.4. Whereas following a higher 2 Gy dose 100% of cells are hit, with an average hit per 
cell of 8.5. Given the cell sizes for each cell type are approximately the same (117 μm2 and 120 
μm2 ,respectively), the difference observed between cell types could not be attributed to differences 
in the fraction of hit cells. Bystander effects may be more prevalent at a lower dose, given 65% of 
the cells are only exposed to bystander effects and not to any direct radiation exposure. Thus, we 
might speculate that the DNA damage induced by bystander damage is less readily repaired by 
fibroblasts. A follow up study to identify if bystander damages are more difficult for fibroblast 
cells to repair could be performed to determine if this speculation has any value.  
In conclusion, the study provides novel evidence of a cell type and dose-dependent 
differences in the induction and resolution of damage, even when different cell types are exposed 
as part of the same 3D organotypic culture. In companion studies future work will define the 




protein based on cell type or dose, to help us confirm the unique dose-dependent resolution of 














CONCLUSION AND FUTURE DIRECTIONS 
Radiation-induced esophageal cancer is a deadly and unfortunate possible outcome of 
radiotherapy. Understanding some of the factors responsible for the sensitivity of this tissue may 
aid in providing strategies to prevent this type of cancer. In this study we used two esophageal 
3D model systems to define radiation quality and dose dependent changes in tissue morphology, 
MAPK/SAPK phospho-protein expression, crosstalk between the TGFβ and ATM pathways, and 
DNA damage and repair kinetics following irradiation as a means to better understand 
esophageal tissue sensitivity.  
An initial observation suggesting a sensitivity of this tissue to radiation was the change in 
the esophageal tissue morphology. Our studies using mouse 3D organoids revealed 
morphological changes in esophageal tissue exhibiting both a radiation quality and dose 
dependence. Significant changes were noted only following the highest 1 Gy dose, and only with 
high LET Fe 600 MeV/u exposure. Although a trend of increasing thickness of tissue with dose 
was also observed following cesium exposure, the changes were not significant.  The underlying 
etiology of the change in tissue thickness is uncertain; however, previous studies using other 3D 
tissue models may give us a hint as to the underlying cause(s). For example, using a human skin 
3D OTC model, Von Neubeck et al., also noted an increase in the thickness of certain layers of 
the skin following high LET exposure and corresponding changes in the skin’s proliferation and 
the differentiation process (von Neubeck et al. 2015). However, the researchers tested a number 
of high LET particles and found tissue changes to be complex and differ depending on the time 




more major role in the effects. These results would suggest that proliferation or improper 
differentiation may underlie the morphological changes in the esophageal tissue that we 
observed. Future studies using specific antibodies to detect changes in proliferation and to 
identify specific cell layer within the tissues would be needed to confirm this. This work would 
also suggest that high LET radiation when used for radiotherapy should be used with caution as 
non-target effects could be more damaging to the esophageal tissue than low LET exposures. 
Cellular adaptations due to radiation exposure likely underlie the tissue morphological 
changes observed. The MAPK/SAPK signaling pathway is an important pathway activated by 
radiation, which impacts the growth and differentiation of tissues. Therefore, we studied 
MAPK/SAPK signaling following high LET Fe 600 MeV/n exposure at both an early (24hr) and 
late timepoint (9 days) in human and mouse organoids (respectively) to provide additional 
information to aid in understanding the esophageal tissue’s radiosensitivity.  
One key dose-dependent difference observed in the MAPK/SAPK stress pathway 
expression was an increase in expression of Erk/MAPK, p53 and MEK1 following a low dose, 
and a decreased expression of this same set of phospho-proteins following a high dose. This 
unique Erk/MAPK phosphorylation profile has been observed previously in human glioma cells, 
indicating that low levels of DSBs can activate ERK pro-survival signaling, whereas higher 
levels instead result in ERK dephosphorylation (Khalil et al. 2011). The latter study also 
observed that Erk/MAPK phosphorylation corresponded with increased levels of double-strand 
breaks and cellular proliferation. In contrast with this finding are our radiation dose-dependent 
tissue morphology changes, as we would expect the lower dose of Fe 600 MeV/n exposure 
resulted in an increased tissue thickness as compared to the higher dose, given it provided more 




enzymes to induce DSB rather than radiation and other temporal, radiation quality, cell type 
differences between our work and theirs may explain the conflicting results observed (2011). In 
addition, the tissue morphology difference we noted was observed in mouse, rather than human 
esophageal organoid tissue, making a direct comparison between the thickening of the tissue and 
phospho-signaling patterns at 24 hr post damage not possible due to the species difference.  
However, mouse organoids were used in our study investigating MAPK/SAPK phospho-
protein signaling patterns at a later nine days-post exposure timepoint. In this work we do reveal 
Fe 600 MeV/u to induce higher levels of Erk/MAPK expression, similar to the study by Khalil et 
al., and that higher doses of exposure result in a significant increase in Erk/MAPK 
phosphorylation. This same finding is also observed in human esophageal organoid tissue at this 
same timepoint (Figure 18 and 20). Thus, the results nine days following 1 Gy Fe 600 MeV/n 
support higher levels of damage initiating greater levels of Erk/MAPK signaling, cellular 
proliferation and resulting in the esophageal tissue thickening that we observed. Other phospho-
proteins such as p38, JNK, and p53 showed a dose-dependent increase in mouse esophageal 
samples nine days post Fe 600 MeV/n irradiation and could also be important in the tissue changes 
observed post radiation. Especially, given p53’s is importance in responding to DNA damage 
(Williams and Schumacher 2016) and p38’s, similar to Erk/MAPK, role in stem cell proliferation 
and cell differentiation (McConnell et al. 2016). Whether esophageal tissue is more sensitive to 
these radiation-induced cellular effects as compared to other tissues is an important question and 
would require additional studies comparing different cell type 3D tissue models to resolve. 
Another important question we strove to understand by probing the ERK/MAPK 
signaling pathway expression patterns, was the importance of two major radiation response 




defining phospho-protein expression patterns at the early 24 hr time point, we observed 
differences that allow us to speculate on potential cross-talk between these pathways in response 
to radiation. We noted unique patterns of expression when organoids were exposed to both 
protein inhibitors, that were different from the expression patterns exhibited with either single 
inhibitor alone. This would imply some crosstalk between the ATM and TGFb pathways in 
regulating specific phospho-protein expression. The evidence of cross talk was also in some 
cases dependent on dose, being observed only in the sham, low or high dose exposed samples 
(Table 1). For example, evidence for cross-talk between the pathways is only noted for JNK 
following a high dose and only noted for MEK1 following a low dose. Yet, there were some 
phospho-proteins, such as p53 and MSK1 that revealed cross-talk between the pathways at both 
the low and high dose. Links between these pathways and p53 have been noted by others, for 
example TGFb has been shown to indirectly stabilize p53, and ATM phosphorylates p53 
following damage (Appella and Anderson 2001, Liu et al. 2017). Of particular importance is the 
fact that crosstalk between TGF-β signaling and p53 is thought to play a critical role in cancer 
progression (Elston and Inman 2012). Further work is needed to define whether the crosstalk we 
observed in esophageal tissue is more aberrantly affected following radiation exposure as 
compared to other tissue types, or differs based on radiation quality, perhaps impacting 
esophageal cancer risk. Nonetheless, these findings provide key areas to follow up on in future 
studies. 
DNA damage is a natural outcome of radiation exposure and the kinetics of their 
induction/resolution have been monitored using antibodies against phospho-proteins that 
accumulate at the sites of DSBs to provide information regarding the cell’s radiation sensitivity 




3D esophageal cellular models to different radiation qualities to define differences in radiation 
quality and dose. In addition, we were able to investigate species specific differences as one model 
system, the OTC, used human cells, and esophageal organoids were produced using mouse cells. 
Furthermore, the OTC is made using both esophageal fibroblast and epithelial cells which allowed 
us to examine cell specific differences as well.  
Focusing first on foci kinetics at early times in the OTC model following Fe600 MeV/n 
exposure, as expected, higher doses of both radiation qualities resulted in higher levels of damage 
in both cell types. In addition, as time proceeded levels continued to reduce, with similar overall 
patterns observed in terms of foci resolution for both gH2AX and 53BP1 (a phospho-protein 
present in the chromatin and one recruited to the damage, respectively). However, when comparing 
the patterns in greater detail some differences are noted between cell types and between the kinetics 
for each phospho-protein. For example, levels of gH2AX tended to be lower for both cell types in 
the first 24 hr, yet higher as compared to 53BP1 foci levels at the later 72 hr timepoint. 
A cell type dependent difference common to both DSB markers was that fibroblast cells 
tended to induce greater numbers of foci positive cells per Gy, which took longer to resolve as 
compared to epithelial cells.  This was especially evident following the lower 0.1 Gy dose, as foci 
numbers remained virtually unchanged over a 72-h period, but reduced to some degree during this 
period following the higher dose. In contrast, our work revealed epithelial cells to repair damage 
from the higher 2 Gy dose more slowly than the lower 0.1 Gy dose when comparing foci resolution 
over time. A similar finding to ours was observed by Rothkamm and Lobrich using fibroblast 
monocultures, which showed that DSBs induced by a low dose of X-ray took longer to resolve 
(Rothkamm and Lobrich 2003), but a much lower dose (1 mGy) was used in this study. Whether 




a role in a greater propensity for cancer years later is uncertain, but given epithelial cells are more 
prone to cancer, and yet we appear to note a greater sensitivity in fibroblast cells, we would deduce 
that early kinetics do not relate to cancer predisposition. In fact, studies have shown that persistent 
foci in cells at much later time are more relevant in understanding a tissue’s propensity to develop 
cancer (Bonner et al. 2008).  
Assessing DNA damage foci kinetics at much later points revealed differences between 
radiation qualities and the kinetics of each DNA DSB marker. Mouse esophageal organoids were 
exposed to either cesium or Fe 600 MeV/n and fixed nine days later to define DNA damage foci 
kinetics. Both gH2AX and 53BP1 kinetics were studied, similar to our work done at 24 hr with 
human organoids. This work revealed a clear dose response following cesium irradiation with a 
greater yield of gH2AX foci and fewer 53BP1 foci induced per unit dose of cesium exposure. In 
contrast following Fe 600 MeV/n exposure, the opposite was true, more 53BP1 foci as compared 
to gH2AX foci were observed per unit dose. It is unclear why differences exist between the 
radiation qualities in terms of the prevalence of a particular DSB marker. However, what is 
consistent is that higher levels of residual foci are present with exposure to higher doses, thus likely 
suggesting a 1 Gy dose, as used in this study, a dose higher than likely to occur in non-target tissue 
during radiotherapy, may lead to changes that increase cancer risk. More studies are needed to 
define the threshold dose for residual foci and to directly compare repair kinetics in different 3D 
cell type models, within the same species, to define the relative radiation sensitivity of esophageal 
tissue to and understand how this may relate to cancer risk.  
In summary, this thesis provides evidence for radiation quality, cell type and species 
dependent radiation effects in esophageal tissue. It also provides evidence for a greater 




Additional time course and dose studies are needed using multiple tissue-type 3D models to better 
define the relative sensitivity of esophageal tissue and to understand molecular mechanisms 


























FOLD CHANGE OVER CONTROL FOR FIGURES 12-17  
 
 











FOLD CHANGE OVER CONTROL FOR FIGURES 18-21  
 
Calculated fold changes for MAPK/SAPK phospho-protein expression levels for human 
and mouse esophageal organoid samples as compared to sham following Fe 600 MeV/n and 
cesium exposures. 
The expression of each phospho-protein was calculated as a fold over the sham for each sample. 
The folds were then used to determine which phospho-proteins had a similar trend in their 
induction, either increasing (>1.2 fold), decreasing (<0.8 fold) or staying approximately the same 
as control expression (1.1 to 0.9). These fold calculations were used to define what phospho-




















 Radiation Quality fold changes for human and Mouse Esophageal samples. Fold change 
comparing Fe600 induced expression to Cs expression was calculated for each species based on 
their respective controls. These calculated folds were used to define which graphs to display 
together in Figure  22 & 23, showing trends of an increase (>1.1 fold), a decrease (<0.9), or no 

























TISSUE SPECIFIC FOLD CHANGE FOR FIGURES 24-25 
 
  
Fold increase or decrease in expression comparing Human vs. Mouse Fold Changes. Fold 
change was calculated for each species based on their respective controls. These calculated folds 
were used to define which graphs to display together in Figure  24 & 25, showing trends of an 





















Appendix Table 1. Number of Foci/cell in Epithelial Cells within OTC Over Time 
  0 1 2 3 4 5 6 7 8 
2 0 836 39 1 3      
0.1 461 58 25 10 4 1    
2 506 139 154 112 66 37 16 7 3 
24 0 117 3        
0.1 479 30 6 1      
2 361 67 45 36 28 8 5 2 1 
72 0 236         
0.1 267 7 1  1     
2 226 32 16 15 7 2    
 
Appendix Table 2. Number of Foci/cell in Fibroblast Cells with OTC Over Time 
  0 1 2 3 4 5 6 7 8 9 
2 0 37 3 5 1       
0.1 70 8 3        
2 14 9 4 6 9 2 2 2  1 
24 0 14 4         
0.1 43 5 1        
2 46 21 4 6       
72 0 6          
0.1 27 2         






An JJ, Shi KJ, Wei W, Hua FY, Ci YL, Jiang Q, Li F, Wu P, Hui KY, Yang Y, Xu CM. The 
ros/jnk/atf2 pathway mediates selenite-induced leukemia nb4 cell cycle arrest and 
apoptosis in vitro and in vivo. Cell death & disease 4: e973; 2013. 
Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic 
stresses. European journal of biochemistry 268: 2764-72; 2001. 
Barbieri S, Babini G, Morini J, Friedland W, Buonanno M, Grilj V, Brenner DJ, Ottolenghi A, 
Baiocco G. Predicting DNA damage foci and their experimental readout with 2d 
microscopy: A unified approach applied to photon and neutron exposures. Scientific 
reports 9: 14019; 2019. 
Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: Current advances and future 
directions. International journal of medical sciences 9: 193-9; 2012. 
Bhoumik A, Takahashi S, Breitweiser W, Shiloh Y, Jones N, Ronai Z. Atm-dependent 
phosphorylation of atf2 is required for the DNA damage response. Molecular cell 18: 
577-87; 2005. 
Blakely EA, Ngo, F.Q.H., Curtis, S.B., Tobias, C.A. Heavy-ion radiobiology: Cellular studies. 
Advances in Radiation Biology 11: 295-389; 1984. 
Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. 
Gammah2ax and cancer. Nature reviews Cancer 8: 957-67; 2008. 
Chai J, Jamal MM. Esophageal malignancy: A growing concern. World journal of 
gastroenterology 18: 6521-6; 2012. 
Chevalier F, Hamdi DH, Lepleux C, Temelie M, Nicol A, Austry JB, Lesueur P, Vares G, Savu 
D, Nakajima T, Saintigny Y. High let radiation overcomes in vitro resistance to x-rays of 
chondrosarcoma cell lines. Technology in cancer research & treatment 18: 
1533033819871309; 2019. 
Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ. Incidence of second 
malignancies among patients treated with proton versus photon radiation. International 
journal of radiation oncology, biology, physics 87: 46-52; 2013. 
Costes SV, Boissiere A, Ravani S, Romano R, Parvin B, Barcellos-Hoff MH. Imaging features 
that discriminate between foci induced by high- and low-let radiation in human 
fibroblasts. Radiation research 165: 505-15; 2006. 
Dancea HC, Shareef MM, Ahmed MM. Role of radiation-induced tgf-beta signaling in cancer 
therapy. Molecular and cellular pharmacology 1: 44-56; 2009. 
Datta K, Suman S, Kallakury BV, Fornace AJ, Jr. Heavy ion radiation exposure triggered higher 
intestinal tumor frequency and greater beta-catenin activation than gamma radiation in 
apc(min/+) mice. PloS one 8: e59295; 2013. 
de Feraudy S, Revet I, Bezrookove V, Feeney L, Cleaver JE. A minority of foci or pan-nuclear 
apoptotic staining of gammah2ax in the s phase after uv damage contain DNA double-
strand breaks. Proceedings of the National Academy of Sciences of the United States of 
America 107: 6870-5; 2010. 
DeNardi FG, Riddell RH. The normal esophagus. The American journal of surgical pathology 
15: 296-309; 1991. 
Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-
Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling 




DeWard AD, Cramer J, Lagasse E. Cellular heterogeneity in the mouse esophagus implicates the 
presence of a nonquiescent epithelial stem cell population. Cell reports 9: 701-11; 2014. 
Dikomey E, Dahm-Daphi J, Brammer I, Martensen R, Kaina B. Correlation between cellular 
radiosensitivity and non-repaired double-strand breaks studied in nine mammalian cell 
lines. International journal of radiation biology 73: 269-78; 1998. 
Doupe DP, Alcolea MP, Roshan A, Zhang G, Klein AM, Simons BD, Jones PH. A single 
progenitor population switches behavior to maintain and repair esophageal epithelium. 
Science 337: 1091-3; 2012. 
Dracham CB, Shankar A, Madan R. Radiation induced secondary malignancies: A review 
article. Radiation oncology journal 36: 85-94; 2018. 
Eaton BR, Esiashvili N, Kim S, Weyman EA, Thornton LT, Mazewski C, MacDonald T, Ebb D, 
MacDonald SM, Tarbell NJ, Yock TI. Clinical outcomes among children with standard-
risk medulloblastoma treated with proton and photon radiation therapy: A comparison of 
disease control and overall survival. International journal of radiation oncology, biology, 
physics 94: 133-138; 2016. 
El-Ashmawy M, Coquelin M, Luitel K, Batten K, Shay JW. Organotypic culture in three 
dimensions prevents radiation-induced transformation in human lung epithelial cells. 
Scientific reports 6: 31669; 2016. 
Elston R, Inman GJ. Crosstalk between p53 and tgf-beta signalling. Journal of signal 
transduction 2012: 294097; 2012. 
Estiar MA, Mehdipour P. Atm in breast and brain tumors: A comprehensive review. Cancer 
biology & medicine 15: 210-227; 2018. 
Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, 
Eleojo Musa A, Najafi M. Tgf-beta in radiotherapy: Mechanisms of tumor resistance and 
normal tissues injury. Pharmacological research 155: 104745; 2020. 
Filippi AR, Vanoni V, Meduri B, Cozzi L, Scorsetti M, Ricardi U, Lohr F. Intensity modulated 
radiation therapy and second cancer risk in adults. International journal of radiation 
oncology, biology, physics 100: 17-20; 2018. 
Gilbert ES, Fry SA, Wiggs LD, Voelz GL, Cragle DL, Petersen GR. Analyses of combined 
mortality data on workers at the hanford site, oak ridge national laboratory, and rocky 
flats nuclear weapons plant. Radiation research 120: 19-35; 1989. 
Groesser T, Chang H, Fontenay G, Chen J, Costes SV, Helen Barcellos-Hoff M, Parvin B, 
Rydberg B. Persistence of gamma-h2ax and 53bp1 foci in proliferating and non-
proliferating human mammary epithelial cells after exposure to gamma-rays or iron ions. 
International journal of radiation biology 87: 696-710; 2011. 
Grudzenski S, Raths A, Conrad S, Rube CE, Lobrich M. Inducible response required for repair 
of low-dose radiation damage in human fibroblasts. Proceedings of the National 
Academy of Sciences of the United States of America 107: 14205-10; 2010. 
Haber AH, Rothstein BE. Radiosensitivity and rate of cell division: "Law of bergonie and 
tribondeau". Science 163: 1338-9; 1969. 
Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3d-crt and imrt. 
International journal of radiation oncology, biology, physics 56: 83-8; 2003. 
Han W, Yu, K.N. Ionizing radiation, DNA double strand break and mutation. Advances in 
Genetics Research 4: 1-13; 2010. 
Harding SM, Bristow RG. Discordance between phosphorylation and recruitment of 53bp1 in 




Kalabis J, Wong GS, Vega ME, Natsuizaka M, Robertson ES, Herlyn M, Nakagawa H, Rustgi 
AK. Isolation and characterization of mouse and human esophageal epithelial cells in 3d 
organotypic culture. Nature protocols 7: 235-46; 2012. 
Khalil A, Morgan RN, Adams BR, Golding SE, Dever SM, Rosenberg E, Povirk LF, Valerie K. 
Atm-dependent erk signaling via akt in response to DNA double-strand breaks. Cell cycle 
10: 481-91; 2011. 
Kirshner J, Jobling MF, Pajares MJ, Ravani SA, Glick AB, Lavin MJ, Koslov S, Shiloh Y, 
Barcellos-Hoff MH. Inhibition of transforming growth factor-beta1 signaling attenuates 
ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer research 66: 
10861-9; 2006. 
Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. Tgf-beta - an excellent servant but a bad 
master. Journal of translational medicine 10: 183; 2012. 
Kurashige T, Shimamura M, Nagayama Y. Differences in quantification of DNA double-strand 
breaks assessed by 53bp1/gammah2ax focus formation assays and the comet assay in 
mammalian cells treated with irradiation and n-acetyl-l-cysteine. Journal of radiation 
research 57: 312-7; 2016. 
Kurokowa M, Lynch K, Podolsky DK. Effects of growth factors on an intestinal epithelial cell 
line: Transforming growth factor beta inhibits proliferation and stimulates differentiation. 
Biochemical and biophysical research communications 142: 775-82; 1987. 
Labay E, Efimova EV, Quarshie BK, Golden DW, Weichselbaum RR, Kron SJ. Ionizing 
radiation-induced foci persistence screen to discover enhancers of accelerated 
senescence. International journal of high throughput screening 2: 1-13; 2011. 
Lamart S, Stovall M, Simon SL, Smith SA, Weathers RE, Howell RM, Curtis RE, Aleman BM, 
Travis L, Kwon D, Morton LM. Radiation dose to the esophagus from breast cancer 
radiation therapy, 1943-1996: An international population-based study of 414 patients. 
International journal of radiation oncology, biology, physics 86: 694-701; 2013. 
Lau E, Ronai ZA. Atf2 - at the crossroad of nuclear and cytosolic functions. Journal of cell 
science 125: 2815-24; 2012. 
Lee JH, Goodarzi AA, Jeggo PA, Paull TT. 53bp1 promotes atm activity through direct 
interactions with the mrn complex. The EMBO journal 29: 574-85; 2010. 
Li CI, Nishi N, McDougall JA, Semmens EO, Sugiyama H, Soda M, Sakata R, Hayashi M, 
Kasagi F, Suyama A, Mabuchi K, Davis S, Kodama K, Kopecky KJ. Relationship 
between radiation exposure and risk of second primary cancers among atomic bomb 
survivors. Cancer research 70: 7187-98; 2010. 
Li Y, Liu Y, Chiang YJ, Huang F, Li Y, Li X, Ning Y, Zhang W, Deng H, Chen YG. DNA 
damage activates tgf-beta signaling via atm-c-cbl-mediated stabilization of the type ii 
receptor tbetarii. Cell reports 28: 735-745 e4; 2019. 
Liang X, So YH, Cui J, Ma K, Xu X, Zhao Y, Cai L, Li W. The low-dose ionizing radiation 
stimulates cell proliferation via activation of the mapk/erk pathway in rat cultured 
mesenchymal stem cells. Journal of radiation research 52: 380-6; 2011. 
Liu WT, Huang KY, Lu MC, Huang HL, Chen CY, Cheng YL, Yu HC, Liu SQ, Lai NS, Huang 
HB. Tgf-beta upregulates the translation of usp15 via the pi3k/akt pathway to promote 
p53 stability. Oncogene 36: 2715-2723; 2017. 
Lobrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, Barton O, Jeggo PA. 
Gammah2ax foci analysis for monitoring DNA double-strand break repair: Strengths, 




Marechal A, Zou L. DNA damage sensing by the atm and atr kinases. Cold Spring Harbor 
perspectives in biology 5; 2013. 
Mariotti LG, Pirovano G, Savage KI, Ghita M, Ottolenghi A, Prise KM, Schettino G. Use of the 
gamma-h2ax assay to investigate DNA repair dynamics following multiple radiation 
exposures. PloS one 8: e79541; 2013. 
Marques-Pereira JP, Leblond CP. Mitosis and differentiation in the stratified squamous 
epithelium of the rat esophagus. The American journal of anatomy 117: 73-87; 1965. 
Martin ML, Adileh M, Hsu KS, Hua G, Lee SG, Li C, Fuller JD, Rotolo JA, Bodo S, Klingler S, 
Haimovitz-Friedman A, Deasy JO, Fuks Z, Paty PB, Kolesnick RN. Organoids reveal 
that inherent radiosensitivity of small and large intestinal stem cells determines organ 
sensitivity. Cancer research 80: 1219-1227; 2020. 
Mauviel A. Transforming growth factor-beta signaling in skin: Stromal to epithelial cross-talk. 
The Journal of investigative dermatology 129: 7-9; 2009. 
McConnell AM, Yao C, Yeckes AR, Wang Y, Selvaggio AS, Tang J, Kirsch DG, Stripp BR. 
P53 regulates progenitor cell quiescence and differentiation in the airway. Cell reports 
17: 2173-2182; 2016. 
McCoy CE, macdonald A, Morrice NA, Campbell DG, Deak M, Toth R, McIlrath J, Arthur JS. 
Identification of novel phosphorylation sites in msk1 by precursor ion scanning ms. The 
Biochemical journal 402: 491-501; 2007. 
Michaylira CZ, Wong GS, Miller CG, Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto 
AJ, Lee JS, Kim SB, Herlyn M, Diehl JA, Gimotty P, Rustgi AK. Periostin, a cell 
adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a 
novel tumor-invasive signature in esophageal cancer. Cancer research 70: 5281-92; 2010. 
Micke O, Schafer U, Glashorster M, Prott FJ, Willich N. Radiation-induced esophageal 
carcinoma 30 years after mediastinal irradiation: Case report and review of the literature. 
Japanese journal of clinical oncology 29: 164-70; 1999. 
Minieri V, Saviozzi S, Gambarotta G, Lo Iacono M, Accomasso L, Cibrario Rocchietti E, 
Gallina C, Turinetto V, Giachino C. Persistent DNA damage-induced premature 
senescence alters the functional features of human bone marrow mesenchymal stem cells. 
Journal of cellular and molecular medicine 19: 734-43; 2015. 
Moeglin E, Desplancq D, Conic S, Oulad-Abdelghani M, Stoessel A, Chiper M, Vigneron M, 
Didier P, Tora L, Weiss E. Uniform widespread nuclear phosphorylation of histone h2ax 
is an indicator of lethal DNA replication stress. Cancers 11; 2019. 
Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, 
Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, 
Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Jr., Brown LM, van 
Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM. 
Risk of treatment-related esophageal cancer among breast cancer survivors. Annals of 
oncology : official journal of the European Society for Medical Oncology 23: 3081-91; 
2012. 
Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, 
Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, 
Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, 
Travis LB, Lamart S, Simon SL, Fraumeni JF, Jr., Aleman BM, Curtis RE. Risk of 





Narang H, Krishna M. Mitogen-activated protein kinases: Specificity of response to dose of 
ionizing radiation in liver. Journal of radiation research 45: 213-20; 2004. 
Natsuizaka M, Ohashi S, Wong GS, Ahmadi A, Kalman RA, Budo D, Klein-Szanto AJ, Herlyn 
M, Diehl JA, Nakagawa H. Insulin-like growth factor-binding protein-3 promotes 
transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and 
motility in transformed human esophageal cells. Carcinogenesis 31: 1344-53; 2010. 
Newhauser WD, Durante M. Assessing the risk of second malignancies after modern 
radiotherapy. Nature reviews Cancer 11: 438-48; 2011. 
Nickoloff JA, Sharma N, Taylor L. Clustered DNA double-strand breaks: Biological effects and 
relevance to cancer radiotherapy. Genes 11; 2020. 
Niedzielski JS, Yang J, Mohan R, Titt U, Mirkovic D, Stingo F, Liao Z, Gomez DR, Martel MK, 
Briere TM, Court LE. Differences in normal tissue response in the esophagus between 
proton and photon radiation therapy for non-small cell lung cancer using in vivo imaging 
biomarkers. International journal of radiation oncology, biology, physics 99: 1013-1020; 
2017. 
Niemantsverdriet M, van Goethem MJ, Bron R, Hogewerf W, Brandenburg S, Langendijk JA, 
van Luijk P, Coppes RP. High and low let radiation differentially induce normal tissue 
damage signals. International journal of radiation oncology, biology, physics 83: 1291-7; 
2012. 
Noda A. Radiation-induced unrepairable dsbs: Their role in the late effects of radiation and 
possible applications to biodosimetry. Journal of radiation research 59: ii114-ii120; 2018. 
Oezcelik A, DeMeester SR. General anatomy of the esophagus. Thoracic surgery clinics 21: 289-
97, x; 2011. 
Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, van der Burgt C, Kooistra 
K, Bos JL, Maassen JA, van Dam H. Growth factors can activate atf2 via a two-step 
mechanism: Phosphorylation of thr71 through the ras-mek-erk pathway and of thr69 
through ralgds-src-p38. The EMBO journal 21: 3782-93; 2002. 
Overstreet JM, Samarakoon R, Cardona-Grau D, Goldschmeding R, Higgins PJ. Tumor 
suppressor ataxia telangiectasia mutated functions downstream of tgf-beta1 in 
orchestrating profibrotic responses. FASEB journal : official publication of the 
Federation of American Societies for Experimental Biology 29: 1258-68; 2015. 
Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A. Survival and secondary tumors in children 
with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: Results of 
children's oncology group trial a9961. Neuro-oncology 15: 97-103; 2013. 
Pang D, Winters TA, Jung M, Purkayastha S, Cavalli LR, Chasovkikh S, Haddad BR, Dritschilo 
A. Radiation-generated short DNA fragments may perturb non-homologous end-joining 
and induce genomic instability. Journal of radiation research 52: 309-19; 2011. 
Panier S, Boulton SJ. Double-strand break repair: 53bp1 comes into focus. Nature reviews 
Molecular cell biology 15: 7-18; 2014. 
Park S, Kang JM, Kim SJ, Kim H, Hong S, Lee YJ, Kim SJ. Smad7 enhances atm activity by 
facilitating the interaction between atm and mre11-rad50-nbs1 complex in DNA double-
strand break repair. Cellular and molecular life sciences : CMLS 72: 583-596; 2015. 
Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 381: 400-12; 
2013. 
Raivich G. C-jun expression, activation and function in neural cell death, inflammation and 




Rehman JU, Isa M, Ahmad N, Nasar G, Asghar H, Gilani ZA, Chow JCL, Afzal M, Ibbott GS. 
Dosimetric, radiobiological and secondary cancer risk evaluation in head-and-neck three-
dimensional conformal radiation therapy, intensity-modulated radiation therapy, and 
volumetric modulated arc therapy: A phantom study. Journal of medical physics 43: 129-
135; 2018. 
Ricoul M, Gnana Sekaran TS, Brochard P, Herate C, Sabatier L. Gamma-h2ax foci persistence at 
chromosome break suggests slow and faithful repair phases restoring chromosome 
integrity. Cancers 11; 2019. 
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce 
histone h2ax phosphorylation on serine 139. The Journal of biological chemistry 273: 
5858-68; 1998. 
Rothkamm K, Barnard S, Moquet J, Ellender M, Rana Z, Burdak-Rothkamm S. DNA damage 
foci: Meaning and significance. Environmental and molecular mutagenesis 56: 491-504; 
2015. 
Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells 
exposed to very low x-ray doses. Proceedings of the National Academy of Sciences of 
the United States of America 100: 5057-62; 2003. 
Samarakoon R, Dobberfuhl AD, Cooley C, Overstreet JM, Patel S, Goldschmeding R, Meldrum 
KK, Higgins PJ. Induction of renal fibrotic genes by tgf-beta1 requires egfr activation, 
p53 and reactive oxygen species. Cellular signalling 25: 2198-209; 2013. 
Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, 
Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, 
Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, 
Lugtenburg PJ, van Leeuwen FE. Second cancer risk up to 40 years after treatment for 
hodgkin's lymphoma. The New England journal of medicine 373: 2499-511; 2015. 
Schena M, Battaglia AF, Munoz F. Esophageal cancer developed in a radiated field: Can we 
reduce the risk of a poor prognosis cancer? Journal of thoracic disease 9: 1767-1771; 
2017. 
Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. P53 binding protein 1 (53bp1) is an early 
participant in the cellular response to DNA double-strand breaks. The Journal of cell 
biology 151: 1381-90; 2000. 
Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Ionizing radiation regulates 
expression of the c-jun protooncogene. Proceedings of the National Academy of Sciences 
of the United States of America 87: 5663-6; 1990. 
Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. Journal of the National Cancer 
Institute Monographs: 7-15; 2001. 
Sridharan DM, Asaithamby A, Bailey SM, Costes SV, Doetsch PW, Dynan WS, Kronenberg A, 
Rithidech KN, Saha J, Snijders AM, Werner E, Wiese C, Cucinotta FA, Pluth JM. 
Understanding cancer development processes after hze-particle exposure: Roles of ros, 
DNA damage repair and inflammation. Radiation research 183: 1-26; 2015. 
Suzuki K, Kodama S, Watanabe M. Extremely low-dose ionizing radiation causes activation of 
mitogen-activated protein kinase pathway and enhances proliferation of normal human 
diploid cells. Cancer research 61: 5396-401; 2001. 
Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, 
Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, 




Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH. Cancer survivorship--
genetic susceptibility and second primary cancers: Research strategies and 
recommendations. Journal of the National Cancer Institute 98: 15-25; 2006. 
Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, Lavia P, Soddu S, Cundari E. 
P53 localization at centrosomes during mitosis and postmitotic checkpoint are atm-
dependent and require serine 15 phosphorylation. Molecular biology of the cell 15: 3751-
7; 2004. 
Tu WZ, Li B, Huang B, Wang Y, Liu XD, Guan H, Zhang SM, Tang Y, Rang WQ, Zhou PK. 
Gammah2ax foci formation in the absence of DNA damage: Mitotic h2ax 
phosphorylation is mediated by the DNA-pkcs/chk2 pathway. FEBS letters 587: 3437-43; 
2013. 
Umar SB, Fleischer, D.E. Esophageal cancer: Epidemiology, pathogenesis and prevention. 
Nature clinical practice Gastroenterology & hepatology 5: 517-26; 2008. 
von Neubeck C, Geniza MJ, Kauer PM, Robinson RJ, Chrisler WB, Sowa MB. The effect of low 
dose ionizing radiation on homeostasis and functional integrity in an organotypic human 
skin model. Mutation research 775: 10-8; 2015. 
Wang G, Jiao H, Zheng JN, Sun X. Hsp27 regulates tgf-beta mediated lung fibroblast 
differentiation through the smad3 and erk pathways. International journal of molecular 
medicine 39: 183-190; 2017. 
Wang M, Hada M, Huff J, Pluth JM, Anderson J, O'Neill P, Cucinotta FA. Heavy ions can 
enhance tgfbeta mediated epithelial to mesenchymal transition. Journal of radiation 
research 53: 51-7; 2012. 
Wang M, Saha J, Hada M, Anderson JA, Pluth JM, O'Neill P, Cucinotta FA. Novel smad 
proteins localize to ir-induced double-strand breaks: Interplay between tgfbeta and atm 
pathways. Nucleic acids research 41: 933-42; 2013. 
Werner E, Wang H, Doetsch PW. Opposite roles for p38mapk-driven responses and reactive 
oxygen species in the persistence and resolution of radiation-induced genomic instability. 
PloS one 9: e108234; 2014. 
Whelan KA, Muir AB, Nakagawa H. Esophageal 3d culture systems as modeling tools in 
esophageal epithelial pathobiology and personalized medicine. Cellular and molecular 
gastroenterology and hepatology 5: 461-478; 2018. 
Wiegman EM, Blaese MA, Loeffler H, Coppes RP, Rodemann HP. Tgfbeta-1 dependent fast 
stimulation of atm and p53 phosphorylation following exposure to ionizing radiation does 
not involve tgfbeta-receptor i signalling. Radiotherapy and oncology : journal of the 
European Society for Therapeutic Radiology and Oncology 83: 289-95; 2007. 
Wiggs LD, Johnson ER, Cox-DeVore CA, Voelz GL. Mortality through 1990 among white male 
workers at the los alamos national laboratory: Considering exposures to plutonium and 
external ionizing radiation. Health physics 67: 577-88; 1994. 
Willers H, Gheorghiu L, Liu Q, Efstathiou JA, Wirth LJ, Krause M, von Neubeck C. DNA 
damage response assessments in human tumor samples provide functional biomarkers of 
radiosensitivity. Seminars in radiation oncology 25: 237-50; 2015. 
Williams AB, Schumacher B. P53 in the DNA-damage-repair process. Cold Spring Harbor 
perspectives in medicine 6; 2016. 
Wu R, Chen, Y., Du, Y., Du, G., Hu, B., Wu, L. Bystander effects induces by the monolayer and 




Yan YX, Nakagawa H, Lee MH, Rustgi AK. Transforming growth factor-alpha enhances cyclin 
d1 transcription through the binding of early growth response protein to a cis-regulatory 
element in the cyclin d1 promoter. The Journal of biological chemistry 272: 33181-90; 
1997. 
Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L, Xia F, Fu G, Deng Y, Pan M, Guo Q, Gao X, Li Y, 
Rao X, Zhou Y, Liang L, Wang Y, Zhang J, Zhang H, Li G, Zhang L, Peng J, Cai S, Hu 
C, Gao J, Clevers H, Zhang Z, Hua G. Patient-derived organoids predict chemoradiation 
responses of locally advanced rectal cancer. Cell stem cell 26: 17-26 e6; 2020. 
Yazaki E, Sifrim D. Anatomy and physiology of the esophageal body. Diseases of the esophagus 
: official journal of the International Society for Diseases of the Esophagus 25: 292-8; 
2012. 
Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, 
Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ. Long-term 
toxic effects of proton radiotherapy for paediatric medulloblastoma: A phase 2 single-arm 
study. The Lancet Oncology 17: 287-298; 2016. 
Zhang S, Ekman M, Thakur N, Bu S, Davoodpour P, Grimsby S, Tagami S, Heldin CH, 
Landstrom M. Tgfbeta1-induced activation of atm and p53 mediates apoptosis in a 
smad7-dependent manner. Cell cycle 5: 2787-95; 2006. 
Zhang Y, Jiang M, Kim E, Lin S, Liu K, Lan X, Que J. Development and stem cells of the 











Name: Latisha Pryor  
 
Education: University of Nevada, Las Vegas, NV 
   M.S Health Physics 
   August 2017- July 2020 
    
   University of Nevada, Las Vegas, NV 
   B.S Health Physics 
   August 2015-May 2017 
 
   Fort Valley State University  
   B.S Biology  
   August 2012-May 2015  
 
E-mail: latisha.peyor@gmail.com 
